BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov. 2016;15:385-403. [PMID: 26775688 DOI: 10.1038/nrd.2015.17] [Cited by in Crossref: 406] [Cited by in F6Publishing: 394] [Article Influence: 81.2] [Reference Citation Analysis]
Number Citing Articles
1 Azad T, Janse van Rensburg HJ, Lightbody ED, Neveu B, Champagne A, Ghaffari A, Kay VR, Hao Y, Shen H, Yeung B, Croy BA, Guan KL, Pouliot F, Zhang J, Nicol CJB, Yang X. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nat Commun 2018;9:1061. [PMID: 29535383 DOI: 10.1038/s41467-018-03278-w] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 22.7] [Reference Citation Analysis]
2 Kuriyama N, Yoshioka Y, Kikuchi S, Azuma N, Ochiya T. Extracellular Vesicles Are Key Regulators of Tumor Neovasculature. Front Cell Dev Biol 2020;8:611039. [PMID: 33363175 DOI: 10.3389/fcell.2020.611039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Yeldag G, Rice A, Del Río Hernández A. Chemoresistance and the Self-Maintaining Tumor Microenvironment. Cancers (Basel) 2018;10:E471. [PMID: 30487436 DOI: 10.3390/cancers10120471] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 19.3] [Reference Citation Analysis]
4 Nam S. Cancer Transcriptome Dataset Analysis: Comparing Methods of Pathway and Gene Regulatory Network-Based Cluster Identification. OMICS 2017;21:217-24. [PMID: 28388297 DOI: 10.1089/omi.2016.0169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DL. Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res 2018;24:4734-44. [PMID: 29871907 DOI: 10.1158/1078-0432.CCR-17-1523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Cui H, Yang X, Wang Z, Li G, Li L, Huo S, Zhang B, He R, Chen K, Xu B, Wang P, Lei H. Tetrahydropalmatine triggers angiogenesis via regulation of arginine biosynthesis. Pharmacol Res 2021;163:105242. [PMID: 33075491 DOI: 10.1016/j.phrs.2020.105242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Upshaw JN. The Role of Biomarkers to Evaluate Cardiotoxicity. Curr Treat Options Oncol 2020;21:79. [PMID: 32767198 DOI: 10.1007/s11864-020-00777-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Bocca P, Di Carlo E, Caruana I, Emionite L, Cilli M, De Angelis B, Quintarelli C, Pezzolo A, Raffaghello L, Morandi F, Locatelli F, Pistoia V, Prigione I. Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model. Oncoimmunology 2017;7:e1378843. [PMID: 29296542 DOI: 10.1080/2162402X.2017.1378843] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
9 Cignarella A, Fadini GP, Bolego C, Trevisi L, Boscaro C, Sanga V, Seccia TM, Rosato A, Rossi GP, Barton M. Clinical Efficacy and Safety of Angiogenesis Inhibitors: Sex Differences and Current Challenges. Cardiovasc Res 2021:cvab096. [PMID: 33739385 DOI: 10.1093/cvr/cvab096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ospina-Villa JD, Zamorano-Carrillo A, Castañón-Sánchez CA, Ramírez-Moreno E, Marchat LA. Aptamers as a promising approach for the control of parasitic diseases. Braz J Infect Dis 2016;20:610-8. [PMID: 27755981 DOI: 10.1016/j.bjid.2016.08.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
11 Liu X, Zhang L, Wang JH, Zeng H, Zou J, Tan W, Zhao H, He Y, Shi J, Yoshida S, Li Y, Zhou Y. Investigation of circRNA Expression Profiles and Analysis of circRNA-miRNA-mRNA Networks in an Animal (Mouse) Model of Age-Related Macular Degeneration. Curr Eye Res 2020;45:1173-80. [PMID: 31979995 DOI: 10.1080/02713683.2020.1722179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Hamilton JL, Nagao M, Levine BR, Chen D, Olsen BR, Im HJ. Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. J Bone Miner Res 2016;31:911-24. [PMID: 27163679 DOI: 10.1002/jbmr.2828] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 17.0] [Reference Citation Analysis]
13 Coviello V, Marchi B, Sartini S, Quattrini L, Marini AM, Simorini F, Taliani S, Salerno S, Orlandi P, Fioravanti A, Desidero TD, Vullo D, Da Settimo F, Supuran CT, Bocci G, La Motta C. 1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions. J Med Chem 2016;59:6547-52. [DOI: 10.1021/acs.jmedchem.6b00616] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
14 Inan ÜÜ, Baysal Z, Inan S. Long-term changes in retinal layers in patients undergoing intravitreal ranibizumab for neovascular age-related macular degeneration: Retinal layers after anti-VEGF therapy. Int Ophthalmol 2019;39:2721-30. [DOI: 10.1007/s10792-019-01116-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Inan S, Baysal Z, Inan UU. Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up. Curr Eye Res 2019;44:908-15. [PMID: 30909756 DOI: 10.1080/02713683.2019.1600195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Liu C, Zhou X, Zhang Z, Guo Y. Correlation of gene polymorphisms of vascular endothelial growth factor with grade and prognosis of lung cancer. BMC Med Genet 2020;21:86. [PMID: 32354326 DOI: 10.1186/s12881-020-01030-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cai Z, Dong L, Song C, Zhang Y, Zhu C, Zhang Y, Ling Q, Hoffmann PR, Li J, Huang Z, Li W. Methylseleninic Acid Provided at Nutritional Selenium Levels Inhibits Angiogenesis by Down-regulating Integrin β3 Signaling. Sci Rep 2017;7:9445. [PMID: 28842587 DOI: 10.1038/s41598-017-09568-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Chen WS, Cao Z, Leffler H, Nilsson UJ, Panjwani N. Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis. Invest Ophthalmol Vis Sci 2017;58:9-20. [PMID: 28055102 DOI: 10.1167/iovs.16-20009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
19 Rey S, Schito L, Wouters BG, Eliasof S, Kerbel RS. Targeting Hypoxia-Inducible Factors for Antiangiogenic Cancer Therapy. Trends Cancer 2017;3:529-41. [PMID: 28718406 DOI: 10.1016/j.trecan.2017.05.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 12.5] [Reference Citation Analysis]
20 Neill T, Chen CG, Buraschi S, Iozzo RV. Catabolic degradation of endothelial VEGFA via autophagy. J Biol Chem 2020;295:6064-79. [PMID: 32209654 DOI: 10.1074/jbc.RA120.012593] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
21 Caporarello N, Lupo G, Olivieri M, Cristaldi M, Cambria MT, Salmeri M, Anfuso CD. Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions (Review). Mol Med Rep 2017;16:4393-402. [PMID: 28791360 DOI: 10.3892/mmr.2017.7179] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
22 Andón FT, Digifico E, Maeda A, Erreni M, Mantovani A, Alonso MJ, Allavena P. Targeting tumor associated macrophages: The new challenge for nanomedicine. Semin Immunol 2017;34:103-13. [PMID: 28941641 DOI: 10.1016/j.smim.2017.09.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 14.3] [Reference Citation Analysis]
23 Ziemys A, Simic V, Milosevic M, Kojic M, Liu YT, Yokoi K. Attenuated Microcirculation in Small Metastatic Tumors in Murine Liver. Pharmaceutics 2021;13:703. [PMID: 34065867 DOI: 10.3390/pharmaceutics13050703] [Reference Citation Analysis]
24 Luis J, Eastlake K, Khaw PT, Limb GA. Galectins and their involvement in ocular disease and development. Exp Eye Res 2020;197:108120. [PMID: 32565112 DOI: 10.1016/j.exer.2020.108120] [Reference Citation Analysis]
25 Brock T, Boudriot E, Klawitter A, Großer M, Nguyen TTP, Giebe S, Klapproth E, Temme A, El-Armouche A, Breier G. The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium. Int J Mol Sci 2021;22:6049. [PMID: 34205118 DOI: 10.3390/ijms22116049] [Reference Citation Analysis]
26 Kabir AU, Lee TJ, Pan H, Berry JC, Krchma K, Wu J, Liu F, Kang HK, Hinman K, Yang L, Hamilton S, Zhou Q, Veis DJ, Mecham RP, Wickline SA, Miller MJ, Choi K. Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis. JCI Insight 2018;3:97349. [PMID: 29669933 DOI: 10.1172/jci.insight.97349] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
27 Huang K, Que L, Ding Y, Chu N, Qian Z, Shi Y, Qin W, Li Z, Chen Y, Gu X, Wang J, Zhang L, Zhang J, Zhu X, Yang Y, Tang Y, He Q. A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects. Front Pharmacol 2021;12:694375. [PMID: 34220519 DOI: 10.3389/fphar.2021.694375] [Reference Citation Analysis]
28 Yang J, Xu J, Danniel M, Wang X, Wang W, Zeng L, Shen L. The interaction between XBP1 and eNOS contributes to endothelial cell migration. Exp Cell Res 2018;363:262-70. [PMID: 29352987 DOI: 10.1016/j.yexcr.2018.01.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
29 Stumpf C, Wimmer T, Lorenz B, Stieger K. Creation of different bioluminescence resonance energy transfer based biosensors with high affinity to VEGF. PLoS One 2020;15:e0230344. [PMID: 32214330 DOI: 10.1371/journal.pone.0230344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhang Q, Zheng P, Zhu W. Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016-Present). Molecules 2020;25:E2666. [PMID: 32521825 DOI: 10.3390/molecules25112666] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
31 Yamada R, Okawa T, Matsuo K, Suzuki M, Mori N, Mori K. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report. BMC Nephrol. 2019;20:14. [PMID: 30634936 DOI: 10.1186/s12882-018-1194-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
32 Dong ZC, Wu MM, Zhang YL, Wang QS, Liang C, Yan X, Zou LX, Chen C, Han X, Zhang B, Zhang ZR. The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOS/NO signaling in mice. Acta Pharmacol Sin 2021;42:1437-48. [PMID: 33303990 DOI: 10.1038/s41401-020-00569-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wang X, Bove AM, Simone G, Ma B. Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role. Front Cell Dev Biol 2020;8:599281. [PMID: 33304904 DOI: 10.3389/fcell.2020.599281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
34 Bikfalvi A. History and conceptual developments in vascular biology and angiogenesis research: a personal view. Angiogenesis 2017;20:463-78. [DOI: 10.1007/s10456-017-9569-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
35 Riccardi C, Napolitano E, Platella C, Musumeci D, Melone MAB, Montesarchio D. Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics. Med Res Rev 2021;41:464-506. [PMID: 33038031 DOI: 10.1002/med.21737] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
36 Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G. Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med 2017;9:eaak9679. [DOI: 10.1126/scitranslmed.aak9679] [Reference Citation Analysis]
37 Uemura A, Fukushima Y. Rho GTPases in Retinal Vascular Diseases. Int J Mol Sci 2021;22:3684. [PMID: 33916163 DOI: 10.3390/ijms22073684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Allen RC. Molecularly targeted agents in oculoplastic surgery. Curr Opin Ophthalmol 2017;28:485-92. [PMID: 28598870 DOI: 10.1097/ICU.0000000000000403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
39 Barresi E, Tolbatov I, Marzo T, Zappelli E, Marrone A, Re N, Pratesi A, Martini C, Taliani S, Da Settimo F, La Mendola D. Two mixed valence diruthenium(II,III) isomeric complexes show different anticancer properties. Dalton Trans 2021;50:9643-7. [PMID: 34160519 DOI: 10.1039/d1dt01492g] [Reference Citation Analysis]
40 Velez G, Bassuk AG, Colgan D, Tsang SH, Mahajan VB. Therapeutic drug repositioning using personalized proteomics of liquid biopsies. JCI Insight 2017;2:97818. [PMID: 29263305 DOI: 10.1172/jci.insight.97818] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
41 Khanani AM, Patel SS, Ferrone PJ, Osborne A, Sahni J, Grzeschik S, Basu K, Ehrlich JS, Haskova Z, Dugel PU. Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial. JAMA Ophthalmol 2020;138:964-72. [PMID: 32729897 DOI: 10.1001/jamaophthalmol.2020.2699] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 37.0] [Reference Citation Analysis]
42 Joussen AM, Ricci F, Paris LP, Korn C, Quezada-Ruiz C, Zarbin M. Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data. Eye (Lond) 2021;35:1305-16. [PMID: 33564135 DOI: 10.1038/s41433-020-01377-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
43 Shan K, Liu C, Liu B, Chen X, Dong R, Liu X, Zhang Y, Liu B, Zhang S, Wang J, Zhang S, Wu J, Zhao C, Yan B. Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus. Circulation 2017;136:1629-42. [DOI: 10.1161/circulationaha.117.029004] [Cited by in Crossref: 223] [Cited by in F6Publishing: 149] [Article Influence: 55.8] [Reference Citation Analysis]
44 Bazzazi H, Isenberg JS, Popel AS. Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation. Front Physiol 2017;8:48. [PMID: 28220078 DOI: 10.3389/fphys.2017.00048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
45 Negri L, Ferrara N. The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis. Physiol Rev 2018;98:1055-82. [PMID: 29537336 DOI: 10.1152/physrev.00012.2017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
46 Xia Y, Cai XY, Fan JQ, Zhang LL, Ren JH, Li ZY, Zhang RG, Zhu F, Wu G. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms. Int J Cancer 2019;144:2227-38. [PMID: 30374974 DOI: 10.1002/ijc.31958] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
47 Lucarini G, Simonetti O, Lazzarini R, Giantomassi F, Goteri G, Offidani A. Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma. Melanoma Res 2020;30:433-42. [PMID: 32516239 DOI: 10.1097/CMR.0000000000000674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
48 Uemura A, Fruttiger M, D'Amore PA, De Falco S, Joussen AM, Sennlaub F, Brunck LR, Johnson KT, Lambrou GN, Rittenhouse KD, Langmann T. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res 2021;:100954. [PMID: 33640465 DOI: 10.1016/j.preteyeres.2021.100954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Zang J, Liang X, Huang Y, Jia Y, Li X, Xu W, Chou CJ, Zhang Y. Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously. J Med Chem 2018;61:5304-22. [PMID: 29787262 DOI: 10.1021/acs.jmedchem.8b00384] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 12.7] [Reference Citation Analysis]
50 Ruan X, Liang JH, Pan Y, Cai R, Zhang RJ, He Z, Yang X, Niu Z, Jiang W. Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 study. Cancer 2021;127:3163-71. [PMID: 34043812 DOI: 10.1002/cncr.33626] [Reference Citation Analysis]
51 Nojiri T, Arai M, Suzuki Y, Kumazoe M, Tokudome T, Miura K, Hino J, Hosoda H, Miyazato M, Okumura M, Kawaoka S, Kangawa K. Transcriptome analysis reveals a role for the endothelial ANP-GC-A signaling in interfering with pre-metastatic niche formation by solid cancers. Oncotarget 2017;8:65534-47. [PMID: 29029451 DOI: 10.18632/oncotarget.18032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Mohtashami Z, Javar HA, Tehrani MR, Esfahani MR, Roohipour R, Aghajanpour L, Amoli FA, Vakilinezhad MA, Dorkoosh FA. Fabrication, Optimization, and In Vitro and In Vivo Characterization of Intra-vitreal Implant of Budesonide Generally Made of PHBV. AAPS PharmSciTech 2020;21. [DOI: 10.1208/s12249-020-01828-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
53 Garg U, Chauhan S, Nagaich U, Jain N. Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting. Adv Pharm Bull 2019;9:195-204. [PMID: 31380245 DOI: 10.15171/apb.2019.023] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 26.5] [Reference Citation Analysis]
54 Ahmad S, Singh V, Sinha R, Srivastava A, Mandhani A. Role of MMP-2, MMP-9 and VEGF as serum biomarker in early prognosis of renal cell carcinoma. African Journal of Urology 2018;24:255-63. [DOI: 10.1016/j.afju.2018.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
55 Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J, Zhou Z, Zhang W, Qin L, Huang G. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene 2018;37:4094-109. [DOI: 10.1038/s41388-018-0250-z] [Cited by in Crossref: 136] [Cited by in F6Publishing: 140] [Article Influence: 45.3] [Reference Citation Analysis]
56 Citeroni MR, Ciardulli MC, Russo V, Della Porta G, Mauro A, El Khatib M, Di Mattia M, Galesso D, Barbera C, Forsyth NR, Maffulli N, Barboni B. In Vitro Innovation of Tendon Tissue Engineering Strategies. Int J Mol Sci 2020;21:E6726. [PMID: 32937830 DOI: 10.3390/ijms21186726] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
57 Wang Y, Li J, Shao C, Tang X, Du Y, Xu T, Zhao Z, Hu H, Sheng Y, Hu C, Xi Y. Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients. BMC Cancer 2021;21:58. [PMID: 33435917 DOI: 10.1186/s12885-020-07596-5] [Reference Citation Analysis]
58 Hameed S, Bhattarai P, Dai Z. Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment. Sci China Life Sci 2018;61:380-91. [PMID: 29607461 DOI: 10.1007/s11427-017-9256-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
59 Armani G, Madeddu D, Mazzaschi G, Bocchialini G, Sogni F, Frati C, Lorusso B, Falco A, Lagrasta CA, Cavalli S, Mangiaracina C, Vilella R, Becchi G, Gnetti L, Corradini E, Quaini E, Urbanek K, Goldoni M, Carbognani P, Ampollini L, Quaini F. Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer. Eur J Cardiothorac Surg 2018;53:1205-13. [PMID: 29346540 DOI: 10.1093/ejcts/ezx492] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
60 Chen D, Qu X, Shao J, Wang W, Dong X. Anti-vascular nano agents: a promising approach for cancer treatment. J Mater Chem B 2020;8:2990-3004. [PMID: 32211649 DOI: 10.1039/c9tb02957e] [Cited by in Crossref: 13] [Article Influence: 13.0] [Reference Citation Analysis]
61 Truelsen SLB, Mousavi N, Wei H, Harvey L, Stausholm R, Spillum E, Hagel G, Qvortrup K, Thastrup O, Harling H, Mellor H, Thastrup J. The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids. PLoS One 2021;16:e0253258. [PMID: 34234354 DOI: 10.1371/journal.pone.0253258] [Reference Citation Analysis]
62 Deng H, Zhang Z. The application of nanotechnology in immune checkpoint blockade for cancer treatment. J Control Release 2018;290:28-45. [PMID: 30287266 DOI: 10.1016/j.jconrel.2018.09.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
63 Moslehi J, Pandey AK, Bhatia N. Cardio-Oncology: Vascular Endothelial Growth Factor Inhibitors, Salt, and Macrophages: A Complicated Interaction. Hypertension 2017;69:785-6. [DOI: 10.1161/hypertensionaha.117.08703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
64 Lowe J, Wakshull E, Shek T, Chuntharapai A, Elliott R, Rusit J, Maia M. Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum. Journal of Immunological Methods 2018;461:44-52. [DOI: 10.1016/j.jim.2018.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
65 Tiainen L, Korhonen EA, Leppänen VM, Luukkaala T, Hämäläinen M, Tanner M, Lahdenperä O, Vihinen P, Jukkola A, Karihtala P, Aho S, Moilanen E, Alitalo K, Kellokumpu-Lehtinen PL. High baseline Tie1 level predicts poor survival in metastatic breast cancer. BMC Cancer 2019;19:732. [PMID: 31340773 DOI: 10.1186/s12885-019-5959-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
66 Liang P, Ballou B, Lv X, Si W, Bruchez MP, Huang W, Dong X. Monotherapy and Combination Therapy Using Anti-Angiogenic Nanoagents to Fight Cancer. Adv Mater 2021;33:e2005155. [PMID: 33684242 DOI: 10.1002/adma.202005155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
67 Peach CJ, Kilpatrick LE, Woolard J, Hill SJ. Comparison of the ligand-binding properties of fluorescent VEGF-A isoforms to VEGF receptor 2 in living cells and membrane preparations using NanoBRET. Br J Pharmacol 2019;176:3220-35. [PMID: 31162634 DOI: 10.1111/bph.14755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
68 Li M, Kroetz DL. Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacol Ther 2018;182:152-60. [PMID: 28882537 DOI: 10.1016/j.pharmthera.2017.08.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
69 Zhao D, Jiang K, Wang Y, Cheng J, Mo F, Luo T, Guo Y, Zhang C, Song J. Out-of-the-Box Nanocapsules Packed with On-Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy. Adv Healthc Mater 2021;10:e2001803. [PMID: 33433961 DOI: 10.1002/adhm.202001803] [Reference Citation Analysis]
70 Fallah A, Heidari HR, Bradaran B, Sisakht MM, Zeinali S, Molavi O. A gene-based anti-angiogenesis therapy as a novel strategy for cancer treatment. Life Sci 2019;239:117018. [PMID: 31678280 DOI: 10.1016/j.lfs.2019.117018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
71 Yao J, Gao W, Wang Y, Wang L, Diabakte K, Li J, Yang J, Jiang Y, Liu Y, Guo S, Zhao X, Cao Z, Chen X, Li Q, Zhang H, Wang W, Tian Z, Li B, Tian F, Wu G, Pourteymour S, Huang X, Tan F, Cao X, Yang Z, Li K, Zhang Y, Li Y, Zhang Z, Jin H, Tian Y. Sonodynamic Therapy Suppresses Neovascularization in Atherosclerotic Plaques via Macrophage Apoptosis-Induced Endothelial Cell Apoptosis. JACC Basic Transl Sci 2020;5:53-65. [PMID: 32043020 DOI: 10.1016/j.jacbts.2019.10.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
72 Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY, Cai W. ImmunoPET: Concept, Design, and Applications. Chem Rev 2020;120:3787-851. [PMID: 32202104 DOI: 10.1021/acs.chemrev.9b00738] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 57.0] [Reference Citation Analysis]
73 Haggerty AE, Maldonado-Lasunción I, Oudega M. Biomaterials for revascularization and immunomodulation after spinal cord injury. Biomed Mater 2018;13:044105. [PMID: 29359704 DOI: 10.1088/1748-605X/aaa9d8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
74 Paris JL, Villaverde G, Gómez-Graña S, Vallet-Regí M. Nanoparticles for multimodal antivascular therapeutics: Dual drug release, photothermal and photodynamic therapy. Acta Biomater 2020;101:459-68. [PMID: 31706040 DOI: 10.1016/j.actbio.2019.11.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
75 Sangroongruangsri S, Chaikledkaew U, Kumluang S, Wu O, Geue C, Ratanapakorn T, Leelahavarong P, Ingsrisawang L, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Singalavanija A, Hanutsaha P, Kulvichit K, Ratanapojnard T, Wongsawad W, Teerawattananon Y. Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study. Clin Drug Investig 2018;38:853-65. [PMID: 30069864 DOI: 10.1007/s40261-018-0678-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
76 Pandey AK, Singhi EK, Arroyo JP, Ikizler TA, Gould ER, Brown J, Beckman JA, Harrison DG, Moslehi J. Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease. Hypertension 2018;71:e1-8. [PMID: 29279311 DOI: 10.1161/HYPERTENSIONAHA.117.10271] [Cited by in Crossref: 86] [Cited by in F6Publishing: 43] [Article Influence: 21.5] [Reference Citation Analysis]
77 Zarbin MA, Hill L, Maunz A, Gliem M, Stoilov I. Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy. Br J Ophthalmol 2021:bjophthalmol-2020-318688. [PMID: 34039560 DOI: 10.1136/bjophthalmol-2020-318688] [Reference Citation Analysis]
78 Wu J, Zhang Y, Ye L, Wang C. The anti-cancer effects and mechanisms of lactic acid bacteria exopolysaccharides in vitro: A review. Carbohydr Polym 2021;253:117308. [PMID: 33278957 DOI: 10.1016/j.carbpol.2020.117308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
79 Zhang L, Liu Z, Yang K, Kong C, Liu C, Chen H, Huang J, Qian F. Tumor Progression of Non-Small Cell Lung Cancer Controlled by Albumin and Micellar Nanoparticles of Itraconazole, a Multitarget Angiogenesis Inhibitor. Mol Pharm 2017;14:4705-13. [PMID: 29068216 DOI: 10.1021/acs.molpharmaceut.7b00855] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
80 Kashyap AS, Schmittnaegel M, Rigamonti N, Pais-Ferreira D, Mueller P, Buchi M, Ooi CH, Kreuzaler M, Hirschmann P, Guichard A, Rieder N, Bill R, Herting F, Kienast Y, Dirnhofer S, Klein C, Hoves S, Ries CH, Corse E, De Palma M, Zippelius A. Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy. Proc Natl Acad Sci U S A 2020;117:541-51. [PMID: 31889004 DOI: 10.1073/pnas.1902145116] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
81 Comen EA, Bowman RL, Kleppe M. Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment. Front Cell Dev Biol 2018;6:56. [PMID: 29946544 DOI: 10.3389/fcell.2018.00056] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
82 Yau TO. Precision treatment in colorectal cancer: Now and the future. JGH Open 2019;3:361-9. [PMID: 31633039 DOI: 10.1002/jgh3.12153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
83 Itatani Y, Yamamoto T, Zhong C, Molinolo AA, Ruppel J, Hegde P, Taketo MM, Ferrara N. Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer. Proc Natl Acad Sci U S A 2020;117:21598-608. [PMID: 32817421 DOI: 10.1073/pnas.2008112117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
84 Peng K, Bai Y, Zhu Q, Hu B, Xu Y. Targeting VEGF–neuropilin interactions: a promising antitumor strategy. Drug Discovery Today 2019;24:656-64. [DOI: 10.1016/j.drudis.2018.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
85 Jiang Y, Lin X, Tang Z, Lee C, Tian G, Du Y, Yin X, Ren X, Huang L, Ye Z, Chen W, Zhang F, Mi J, Gao Z, Wang S, Chen Q, Xing L, Wang B, Cao Y, Sessa WC, Ju R, Liu Y, Li X. Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK. Proc Natl Acad Sci U S A 2017;114:10737-42. [PMID: 28923916 DOI: 10.1073/pnas.1706394114] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
86 Croci DO, Mendez-huergo SP, Cerliani JP, Rabinovich GA. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies. In: Mandalà M, Romano E, editors. Mechanisms of Drug Resistance in Cancer Therapy. Cham: Springer International Publishing; 2018. pp. 31-61. [DOI: 10.1007/164_2017_29] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
87 Montoya-Zegarra JA, Russo E, Runge P, Jadhav M, Willrodt AH, Stoma S, Nørrelykke SF, Detmar M, Halin C. AutoTube: a novel software for the automated morphometric analysis of vascular networks in tissues. Angiogenesis 2019;22:223-36. [PMID: 30370470 DOI: 10.1007/s10456-018-9652-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
88 Hovinga KE, McCrea HJ, Brennan C, Huse J, Zheng J, Esquenazi Y, Panageas KS, Tabar V. EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma. J Neurooncol 2019;142:337-45. [PMID: 30680510 DOI: 10.1007/s11060-019-03102-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
89 Kiel C, Lastrucci C, Luthert PJ, Serrano L. Simple and complex retinal dystrophies are associated with profoundly different disease networks. Sci Rep 2017;7:41835. [PMID: 28139756 DOI: 10.1038/srep41835] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
90 Qin M, Yan S, Wang L, Zhang H, Tian Y, Zhao Y, Gong P. Novel 6-methoxycarbonyl indolinones bearing a pyrrole Mannich base moiety as angiokinase inhibitors. Bioorganic & Medicinal Chemistry 2017;25:1778-86. [DOI: 10.1016/j.bmc.2017.01.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
91 Li SJ, Chen JX, Sun ZJ. Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges. Cancer Commun (Lond) 2021. [PMID: 34137513 DOI: 10.1002/cac2.12183] [Reference Citation Analysis]
92 Kim JW, Cochran JR. Targeting ligand–receptor interactions for development of cancer therapeutics. Current Opinion in Chemical Biology 2017;38:62-9. [DOI: 10.1016/j.cbpa.2017.03.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
93 Caridi B, Doncheva D, Sivaprasad S, Turowski P. Galectins in the Pathogenesis of Common Retinal Disease. Front Pharmacol 2021;12:687495. [PMID: 34079467 DOI: 10.3389/fphar.2021.687495] [Reference Citation Analysis]
94 Camacho-Villegas TA, Mata-González MT, García-Ubbelohd W, Núñez-García L, Elosua C, Paniagua-Solis JF, Licea-Navarro AF. Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization. Mar Drugs 2018;16:E113. [PMID: 29614715 DOI: 10.3390/md16040113] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
95 Bucolo C, Barbieri A, Viganò I, Marchesi N, Bandello F, Drago F, Govoni S, Zerbini G, Pascale A. Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic Retinopathy. Front Pharmacol 2021;12:707909. [PMID: 34489701 DOI: 10.3389/fphar.2021.707909] [Reference Citation Analysis]
96 Surowy HM, Giesen AK, Otte J, Büttner R, Falkenstein D, Friedl H, Meier F, Petzsch P, Wachtmeister T, Westphal D, Wieczorek D, Wruck W, Adjaye J, Rütten A, Redler S. Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma. Br J Dermatol 2019;180:1150-60. [PMID: 30472730 DOI: 10.1111/bjd.17446] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
97 Lu W, Li X. Vascular stem/progenitor cells: functions and signaling pathways. Cell Mol Life Sci. 2018;75:859-869. [PMID: 28956069 DOI: 10.1007/s00018-017-2662-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
98 Zhou J, Rossi J. Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov 2017;16:181-202. [PMID: 27807347 DOI: 10.1038/nrd.2016.199] [Cited by in Crossref: 643] [Cited by in F6Publishing: 581] [Article Influence: 128.6] [Reference Citation Analysis]
99 Chen Z, Lin Y, Gao J, Lin S, Zheng Y, Liu Y, Chen SQ. Identification of key candidate genes for colorectal cancer by bioinformatics analysis. Oncol Lett 2019;18:6583-93. [PMID: 31788116 DOI: 10.3892/ol.2019.10996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
100 Álvarez-aznar A, Muhl L, Gaengel K. VEGF Receptor Tyrosine Kinases. Protein Kinases in Development and Disease. Elsevier; 2017. pp. 433-82. [DOI: 10.1016/bs.ctdb.2016.10.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
101 Marzo T, La Mendola D. The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics. Curr Top Med Chem 2021;21:73-86. [PMID: 33243124 DOI: 10.2174/1568026620666201126163436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
102 Richter A, Skerra A. Anticalins directed against vascular endothelial growth factor receptor 3 (VEGFR-3) with picomolar affinities show potential for medical therapy and in vivo imaging. Biological Chemistry 2017;398:39-55. [DOI: 10.1515/hsz-2016-0195] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
103 Jung K, Heishi T, Khan OF, Kowalski PS, Incio J, Rahbari NN, Chung E, Clark JW, Willett CG, Luster AD, Yun SH, Langer R, Anderson DG, Padera TP, Jain RK, Fukumura D. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. J Clin Invest. 2017;127:3039-3051. [PMID: 28691930 DOI: 10.1172/jci93182] [Cited by in Crossref: 73] [Cited by in F6Publishing: 49] [Article Influence: 18.3] [Reference Citation Analysis]
104 Zhang J, Ding R, Wu T, Jia J, Cheng X. Autophagy-Related Genes and Long Noncoding RNAs Signatures as Predictive Biomarkers for Osteosarcoma Survival. Front Cell Dev Biol 2021;9:705291. [PMID: 34513835 DOI: 10.3389/fcell.2021.705291] [Reference Citation Analysis]
105 Poolsup S, Kim CY. Therapeutic applications of synthetic nucleic acid aptamers. Curr Opin Biotechnol 2017;48:180-6. [PMID: 28582756 DOI: 10.1016/j.copbio.2017.05.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
106 Zhang L, Zeng H, Wang JH, Zhao H, Zhang B, Zou J, Yoshida S, Zhou Y. Altered Long Non-coding RNAs Involved in Immunological Regulation and Associated with Choroidal Neovascularization in Mice. Int J Med Sci 2020;17:292-301. [PMID: 32132863 DOI: 10.7150/ijms.37804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
107 Grueso E, Sánchez-Martínez C, Calvo-López T, de Miguel FJ, Blanco-Menéndez N, Fernandez-Estevez M, Elizalde M, Sanchez J, Kourani O, Martin D, Tato A, Guerra M, Andrés G, Almendral JM. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions. J Virol 2019;93:e00798-19. [PMID: 31315994 DOI: 10.1128/JVI.00798-19] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Javarsiani MH, Javanmard SH, Colonna F. Metastatic components in colorectal cancer. J Res Med Sci 2019;24:75. [PMID: 31523261 DOI: 10.4103/jrms.JRMS_957_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Zucchelli E, Majid QA, Foldes G. New artery of knowledge: 3D models of angiogenesis. Vasc Biol 2019;1:H135-43. [PMID: 32923965 DOI: 10.1530/VB-19-0026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
110 Di stasi R, Diana D, Capasso D, Di gaetano S, De rosa L, Celentano V, Isernia C, Fattorusso R, D'andrea LD. VEGFR Recognition Interface of a Proangiogenic VEGF-Mimetic Peptide Determined In Vitro and in the Presence of Endothelial Cells by NMR Spectroscopy. Chem Eur J 2018;24:11461-6. [DOI: 10.1002/chem.201802117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
111 Assi T, Watson S, Samra B, Rassy E, Le Cesne A, Italiano A, Mir O. Targeting the VEGF Pathway in Osteosarcoma. Cells 2021;10:1240. [PMID: 34069999 DOI: 10.3390/cells10051240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Gong FL, Wang L, Yu LG, Dang YF, Jiang XN, Zhao L, Guo XL. DHPAC, a novel microtubule depolymerizing agent, suppresses angiogenesis and vasculogenic mimicry formation of human non-small cell lung cancer. J Cell Biochem 2020. [PMID: 32056279 DOI: 10.1002/jcb.29690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Zhang XH, Cao MQ, Li XX, Zhang T. Apatinib as an alternative therapy for advanced hepatocellular carcinoma. World J Hepatol 2020; 12(10): 766-774 [PMID: 33200015 DOI: 10.4254/wjh.v12.i10.766] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Bruno A, Bassani B, D'Urso DG, Pitaku I, Cassinotti E, Pelosi G, Boni L, Dominioni L, Noonan DM, Mortara L, Albini A. Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer. FASEB J 2018;32:5365-77. [PMID: 29763380 DOI: 10.1096/fj.201701103R] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 15.7] [Reference Citation Analysis]
115 Zhang M, Tombran-Tink J, Yang S, Zhang X, Li X, Barnstable CJ. PEDF is an endogenous inhibitor of VEGF-R2 angiogenesis signaling in endothelial cells. Exp Eye Res 2021;213:108828. [PMID: 34742690 DOI: 10.1016/j.exer.2021.108828] [Reference Citation Analysis]
116 Meyer JH, Marx J, Strack C, Holz FG, Schmitz-Valckenberg S. Imaging of Therapeutic Effects of Anti-Vascular Endothelial Growth Factor Inhibitors by Optical Coherence Tomography Angiography in a Rat Model. Transl Vis Sci Technol 2020;9:29. [PMID: 32832234 DOI: 10.1167/tvst.9.7.29] [Reference Citation Analysis]
117 Sahni J, Patel SS, Dugel PU, Khanani AM, Jhaveri CD, Wykoff CC, Hershberger VS, Pauly-Evers M, Sadikhov S, Szczesny P, Schwab D, Nogoceke E, Osborne A, Weikert R, Fauser S. Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial. Ophthalmology 2019;126:1155-70. [PMID: 30905643 DOI: 10.1016/j.ophtha.2019.03.023] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 30.0] [Reference Citation Analysis]
118 Galai G, Ben-David H, Levin L, Orth MF, Grünewald TGP, Pilosof S, Berstein S, Rotblat B. Pan-Cancer Analysis of Mitochondria Chaperone-Client Co-Expression Reveals Chaperone Functional Partitioning. Cancers (Basel) 2020;12:E825. [PMID: 32235444 DOI: 10.3390/cancers12040825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Guarischi-Sousa R, Monteiro JS, Alecrim LC, Michaloski JS, Cardeal LB, Ferreira EN, Carraro DM, Nunes DN, Dias-Neto E, Reimand J, Boutros PC, Setubal JC, Giordano RJ. A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival. PLoS Genet 2019;15:e1008482. [PMID: 31846472 DOI: 10.1371/journal.pgen.1008482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
120 Zhang L, Zhao Y, Dai Y, Cheng JN, Gong Z, Feng Y, Sun C, Jia Q, Zhu B. Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location. Front Immunol 2018;9:1578. [PMID: 30042763 DOI: 10.3389/fimmu.2018.01578] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 20.3] [Reference Citation Analysis]
121 Zhou Y, Li J, Han B, Zhong R, Zhong H. Schwann cells promote lung cancer proliferation by promoting the M2 polarization of macrophages. Cell Immunol 2020;357:104211. [PMID: 32977156 DOI: 10.1016/j.cellimm.2020.104211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Li M, Xu Z, Zhang L, Cui M, Zhu M, Guo Y, Sun R, Han J, Song E, He Y, Su Y. Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic Nanoparticles. ACS Nano 2021;15:9808-19. [PMID: 34037377 DOI: 10.1021/acsnano.1c00680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Yang Y, Yang Y, Yang J, Zhao X, Wei X. Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy. Front Cell Dev Biol 2020;8:758. [PMID: 32850861 DOI: 10.3389/fcell.2020.00758] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
124 Schito L, Rey S. Hypoxia: Turning vessels into vassals of cancer immunotolerance. Cancer Lett 2020;487:74-84. [PMID: 32470491 DOI: 10.1016/j.canlet.2020.05.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
125 Xu T, Wei C, Zou X, Lu B, Wang Z. Case Report: Long-Term Survival With Anlotinib in a Patient With Advanced Undifferentiated Large-Cell Lung Cancer and Rare Tonsillar Metastasis. Front Oncol 2021;11:680818. [PMID: 34249723 DOI: 10.3389/fonc.2021.680818] [Reference Citation Analysis]
126 Qin M, Tian Y, Sun X, Yu S, Xia J, Gong P, Zhang H, Zhao Y. Novel methyl indolinone-6-carboxylates containing an indole moiety as angiokinase inhibitors. European Journal of Medicinal Chemistry 2017;139:492-502. [DOI: 10.1016/j.ejmech.2017.08.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
127 Rust R, Gantner C, Schwab ME. Pro- and antiangiogenic therapies: current status and clinical implications. FASEB J 2019;33:34-48. [PMID: 30085886 DOI: 10.1096/fj.201800640RR] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
128 Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of Diabetic Retinopathy: The Old and the New. Diabetes Metab J 2018;42:364-76. [PMID: 30362302 DOI: 10.4093/dmj.2018.0182] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 18.7] [Reference Citation Analysis]
129 Chen W, Tian X, He W, Li J, Feng Y, Pan G. Emerging functional materials based on chemically designed molecular recognition. BMC Mat 2020;2. [DOI: 10.1186/s42833-019-0007-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 32.0] [Reference Citation Analysis]
130 Goldman A, Bomze D, Dankner R, Fourey D, Boursi B, Arad M, Maor E. Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance Study. Target Oncol 2021;16:471-83. [PMID: 33970401 DOI: 10.1007/s11523-021-00817-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Hu X, Yang W, Du L, Cui W, Mi W, Mao-ying Q, Chu Y, Wang Y. Vascular Endothelial Growth Factor A Signaling Promotes Spinal Central Sensitization and Pain-related Behaviors in Female Rats with Bone Cancer. Anesthesiology 2019;131:1125-47. [DOI: 10.1097/aln.0000000000002916] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
132 Wang L, Coric P, Broussy S, Di Stasi R, Zhou L, D'andrea LD, Ji L, Vidal M, Bouaziz S, Liu W. Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2. European Journal of Medicinal Chemistry 2019;169:65-75. [DOI: 10.1016/j.ejmech.2019.02.069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
133 Fu C, Tyagi R, Chin AC, Rojas T, Li RJ, Guha P, Bernstein IA, Rao F, Xu R, Cha JY, Xu J, Snowman AM, Semenza GL, Snyder SH. Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation. Circ Res 2018;122:457-72. [PMID: 29279301 DOI: 10.1161/CIRCRESAHA.117.311983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
134 Deng C, Zhao J, Zhou S, Dong J, Cao J, Gao J, Bai Y, Deng H. The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors. Mol Ther 2020;28:75-88. [PMID: 31672285 DOI: 10.1016/j.ymthe.2019.10.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
135 Gong G, Zheng Y, Kong X, Wen Z. Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway. J Nat Prod 2021;84:1755-62. [PMID: 34029083 DOI: 10.1021/acs.jnatprod.1c00008] [Reference Citation Analysis]
136 Uemura A. Pharmacologic management of diabetic retinopathy. J Biochem 2018;163:3-9. [PMID: 28992234 DOI: 10.1093/jb/mvx057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
137 Ferrara N. The Role of the VEGF Signaling Pathway in Tumor Angiogenesis. In: Marmé D, editor. Tumor Angiogenesis. Cham: Springer International Publishing; 2019. pp. 211-26. [DOI: 10.1007/978-3-319-33673-2_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Schubert J, Chanana M. Coating Matters: Review on Colloidal Stability of Nanoparticles with Biocompatible Coatings in Biological Media, Living Cells and Organisms. Curr Med Chem 2018;25:4553-86. [PMID: 29852857 DOI: 10.2174/0929867325666180601101859] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
139 Lu J, Shenoy AK. Epithelial-to-Pericyte Transition in Cancer. Cancers (Basel) 2017;9:E77. [PMID: 28677655 DOI: 10.3390/cancers9070077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
140 Zhao D, Huang X, Zhang Z, Ding J, Cui Y, Chen X. Engineered nanomedicines for tumor vasculature blockade therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1691. [PMID: 33480163 DOI: 10.1002/wnan.1691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017;9. [PMID: 28404866 DOI: 10.1126/scitranslmed.aak9679] [Cited by in Crossref: 263] [Cited by in F6Publishing: 255] [Article Influence: 65.8] [Reference Citation Analysis]
142 Tan W, Zou J, Yoshida S, Jiang B, Zhou Y. The Role of Inflammation in Age-Related Macular Degeneration. Int J Biol Sci 2020;16:2989-3001. [PMID: 33061811 DOI: 10.7150/ijbs.49890] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
143 Joseph SK, Sabitha M, Nair SC. Stimuli-Responsive Polymeric Nanosystem for Colon Specific Drug Delivery. Adv Pharm Bull 2020;10:1-12. [PMID: 32002356 DOI: 10.15171/apb.2020.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
144 He H, Li Z, Ni M, Xing S, Yu L, Xu H, Zhuo D, Li M. Screening and stability analysis of reference genes in fasting caecotrophy model in rabbits. Mol Biol Rep 2021. [PMID: 34743273 DOI: 10.1007/s11033-021-06927-4] [Reference Citation Analysis]
145 Zanella S, Bocchinfuso G, De Zotti M, Arosio D, Marino F, Raniolo S, Pignataro L, Sacco G, Palleschi A, Siano AS, Piarulli U, Belvisi L, Formaggio F, Gennari C, Stella L. Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors. Front Chem 2019;7:170. [PMID: 30984741 DOI: 10.3389/fchem.2019.00170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Luo H, Zhang Y, Deng Y, Li L, Sheng Z, Yu Y, Lin Y, Chen X, Feng P. Nxhl Controls Angiogenesis by Targeting VE-PTP Through Interaction With Nucleolin. Front Cell Dev Biol 2021;9:728821. [PMID: 34733844 DOI: 10.3389/fcell.2021.728821] [Reference Citation Analysis]
147 Ronca R, Benkheil M, Mitola S, Struyf S, Liekens S. Tumor angiogenesis revisited: Regulators and clinical implications. Med Res Rev. 2017;37:1231-1274. [PMID: 28643862 DOI: 10.1002/med.21452] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 20.0] [Reference Citation Analysis]
148 Pérez-callejo D, Torrente M, Brenes MA, Núñez B, Provencio M. Lung cancer as a cardiotoxic state: a review. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-1012-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
149 Weyergang A, Fremstedal AS, Skarpen E, Peng Q, Mohamedali KA, Eng MS, Cheung LH, Rosenblum MG, Waltenberger J, Berg K. Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy. J Control Release 2018;288:161-72. [PMID: 30217739 DOI: 10.1016/j.jconrel.2018.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
150 Gacche RN, Assaraf YG. Redundant angiogenic signaling and tumor drug resistance. Drug Resistance Updates 2018;36:47-76. [DOI: 10.1016/j.drup.2018.01.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 14.7] [Reference Citation Analysis]
151 Jászai J, Schmidt MHH. Trends and Challenges in Tumor Anti-Angiogenic Therapies. Cells 2019;8:E1102. [PMID: 31540455 DOI: 10.3390/cells8091102] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 28.0] [Reference Citation Analysis]
152 Pan J, Yang C, Jiang Z, Huang J. Trametes robiniophila Murr: a traditional Chinese medicine with potent anti-tumor effects. Cancer Manag Res 2019;11:1541-9. [PMID: 30863164 DOI: 10.2147/CMAR.S193174] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
153 Tong M, Wang J, Zhang H, Xing H, Wang Y, Fang Y, Pan H, Li D. Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized phase III trials. J Cancer 2019;10:968-78. [PMID: 30854103 DOI: 10.7150/jca.26672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
154 Figueira J, Henriques J, Carneiro Â, Marques-Neves C, Flores R, Castro-Sousa JP, Meireles A, Gomes N, Nascimento J, Amaro M, Silva R. Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization. Clin Ophthalmol 2021;15:3221-30. [PMID: 34354341 DOI: 10.2147/OPTH.S318026] [Reference Citation Analysis]
155 Shu C, Sun P, Xie H, Huang W, Qi J, Ma Y. Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice. Int J Nanomedicine 2020;15:1983-96. [PMID: 32308382 DOI: 10.2147/IJN.S237182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
156 Famili A, Crowell SR, Loyet KM, Mandikian D, Boswell CA, Cain D, Chan J, Comps-Agrar L, Kamath A, Rajagopal K. Hyaluronic Acid-Antibody Fragment Bioconjugates for Extended Ocular Pharmacokinetics. Bioconjug Chem 2019;30:2782-9. [PMID: 31553572 DOI: 10.1021/acs.bioconjchem.9b00475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
157 Zhan C, Deipolyi AR, Erinjeri JP. Wound Healing Failure Following Venous Access Chest Port Placement Associated with Ramucirumab Therapy. Cardiovasc Intervent Radiol 2017;40:1804-6. [DOI: 10.1007/s00270-017-1752-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Peng X, Sun Z, Kuang P, Chen J. Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment. European Journal of Medicinal Chemistry 2020;208:112831. [DOI: 10.1016/j.ejmech.2020.112831] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
159 Tauriello DV, Calon A, Lonardo E, Batlle E. Determinants of metastatic competency in colorectal cancer. Mol Oncol. 2017;11:97-119. [PMID: 28085225 DOI: 10.1002/1878-0261.12018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 17.5] [Reference Citation Analysis]
160 Shah F, Logsdon D, Messmann RA, Fehrenbacher JC, Fishel ML, Kelley MR. Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic. NPJ Precis Oncol 2017;1:19. [PMID: 28825044 DOI: 10.1038/s41698-017-0023-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
161 Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: TLR3 agonists in cancer therapy. Oncoimmunology 2020;9:1771143. [PMID: 32934877 DOI: 10.1080/2162402X.2020.1771143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
162 Zhang L, Liu Z, Kong C, Liu C, Yang K, Chen H, Huang J, Qian F. Improving Drug Delivery of Micellar Paclitaxel against Non-Small Cell Lung Cancer by Coloading Itraconazole as a Micelle Stabilizer and a Tumor Vascular Manipulator. Small 2018;14:e1802112. [PMID: 30444572 DOI: 10.1002/smll.201802112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
163 Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE, Woolard J. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2. Int J Mol Sci. 2018;19:pii: E1264. [PMID: 29690653 DOI: 10.3390/ijms19041264] [Cited by in Crossref: 112] [Cited by in F6Publishing: 104] [Article Influence: 37.3] [Reference Citation Analysis]
164 Demir N, Sevincli S, Kayhan B, Sonmez M. Anatomical effects of intravitreal anti-vascular endothelial growth factor injections on inner layers of the lesion-free retina. Cutan Ocul Toxicol 2021;40:135-9. [PMID: 33944638 DOI: 10.1080/15569527.2021.1919136] [Reference Citation Analysis]
165 Grant ZL, Coultas L. Growth factor signaling pathways in vascular development and disease. Growth Factors 2019;37:53-67. [PMID: 31284789 DOI: 10.1080/08977194.2019.1635591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
166 Ceci C, Atzori MG, Lacal PM, Graziani G. Role of VEGFs/VEGFR-1 Signaling and its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models. Int J Mol Sci 2020;21:E1388. [PMID: 32085654 DOI: 10.3390/ijms21041388] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 38.0] [Reference Citation Analysis]
167 Gao S, Yang D, Fang Y, Lin X, Jin X, Wang Q, Wang X, Ke L, Shi K. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy. Theranostics 2019;9:126-51. [PMID: 30662558 DOI: 10.7150/thno.29431] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 28.0] [Reference Citation Analysis]
168 Montor WR, Salas AROSE, Melo FHM. Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors. Mol Cancer 2018;17:55. [PMID: 29455659 DOI: 10.1186/s12943-018-0792-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
169 Huang L, Zhang X, Bai Y, Chua KLM, Xie Y, Shu X, Long B, Fan C, Lim DWT, Tan SH, Wee JTS, Wang Y, Wu Y, Chua MLK. Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study. Oral Oncol 2021;115:105222. [PMID: 33610004 DOI: 10.1016/j.oraloncology.2021.105222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, Fucikova J, Spisek R, Demaria S, Formenti SC, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology 2017;6:e1373237. [PMID: 29147629 DOI: 10.1080/2162402X.2017.1373237] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
171 Liang C, Zhou A, Sui C, Huang Z. The effect of formononetin on the proliferation and migration of human umbilical vein endothelial cells and its mechanism. Biomedicine & Pharmacotherapy 2019;111:86-90. [DOI: 10.1016/j.biopha.2018.12.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
172 Cui J, Chen Z, Wu W. Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy. Exp Ther Med 2019;18:3502-8. [PMID: 31602226 DOI: 10.3892/etm.2019.7968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
173 Sun M, Qian Q, Shi L, Xu L, Liu Q, Zhou L, Zhu X, Yue J, Yan D. Amphiphilic drug-drug conjugate for cancer therapy with combination of chemotherapeutic and antiangiogenesis drugs. Sci China Chem 2020;63:35-41. [DOI: 10.1007/s11426-019-9602-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
174 Protopsaltis NJ, Liang W, Nudleman E, Ferrara N. Interleukin-22 promotes tumor angiogenesis. Angiogenesis 2019;22:311-23. [PMID: 30539314 DOI: 10.1007/s10456-018-9658-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
175 Bais C, Mueller B, Brady MF, Mannel RS, Burger RA, Wei W, Marien KM, Kockx MM, Husain A, Birrer MJ; NRG Oncology/Gynecologic Oncology Group. Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses. J Natl Cancer Inst 2017;109. [PMID: 29059426 DOI: 10.1093/jnci/djx066] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
176 Sahni J, Dugel PU, Patel SS, Chittum ME, Berger B, Del Valle Rubido M, Sadikhov S, Szczesny P, Schwab D, Nogoceke E, Weikert R, Fauser S. Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial. JAMA Ophthalmol 2020;138:955-63. [PMID: 32729888 DOI: 10.1001/jamaophthalmol.2020.2685] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
177 Michaloski JS, Redondo AR, Magalhães LS, Cambui CC, Giordano RJ. Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors. Sci Adv 2016;2:e1600611. [PMID: 27819042 DOI: 10.1126/sciadv.1600611] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
178 Zeng Y, Yao X, Liu X, He X, Li L, Liu X, Yan Z, Wu J, Fu BM. Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracell Vesicles 2019;8:1629865. [PMID: 31258881 DOI: 10.1080/20013078.2019.1629865] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 19.0] [Reference Citation Analysis]
179 Cabo M, Offringa R, Zitvogel L, Kroemer G, Muntasell A, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. Oncoimmunology 2017;6:e1371896. [PMID: 29209572 DOI: 10.1080/2162402X.2017.1371896] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
180 Zhang K, Ma X, Gao H, Wang H, Qin H, Yang S, Liu X. Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study. Cancer Manag Res 2020;12:3409-17. [PMID: 32494205 DOI: 10.2147/CMAR.S246000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
181 Touyz RM, Herrmann J. Cardiotoxicity with vascular endothelial growth factor inhibitor therapy. NPJ Precis Oncol 2018;2:13. [PMID: 30202791 DOI: 10.1038/s41698-018-0056-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 18.7] [Reference Citation Analysis]
182 Calvanese L, Caporale A, Focà G, Iaccarino E, Sandomenico A, Doti N, Apicella I, Incisivo GM, De Falco S, Falcigno L, D’auria G, Ruvo M. Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications. Amino Acids 2018;50:321-9. [DOI: 10.1007/s00726-017-2519-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
183 Li H, Yan R, Chen W, Ding X, Liu J, Chen G, Zhao Q, Tang Y, Lv S, Liu S, Yu Y. Long non coding RNA SLC26A4-AS1 exerts antiangiogenic effects in human glioma by upregulating NPTX1 via NFKB1 transcriptional factor. FEBS J 2021;288:212-28. [PMID: 32255252 DOI: 10.1111/febs.15325] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
184 Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL. Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook. Cancer Treat Rev 2020;86:102017. [PMID: 32335505 DOI: 10.1016/j.ctrv.2020.102017] [Cited by in Crossref: 98] [Cited by in F6Publishing: 98] [Article Influence: 98.0] [Reference Citation Analysis]
185 Li Z, Li C, Bao R, Liu Z. Expressions of miR-29a, TNF-Α and Vascular Endothelial Growth Factor in Peripheral Blood of Pulmonary Tuberculosis Patients and Their Clinical Significance. Iran J Public Health 2020;49:1683-91. [PMID: 33643943 DOI: 10.18502/ijph.v49i9.4085] [Reference Citation Analysis]
186 Morotti M, Dass PH, Harris AL, Lord S. Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients. Eur J Drug Metab Pharmacokinet 2018;43:137-53. [PMID: 29019020 DOI: 10.1007/s13318-017-0442-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
187 Morbidelli L, Monti M, Terzuoli E. Pharmacological Tools for the Study of H2S Contribution to Angiogenesis. Methods Mol Biol 2019;2007:151-66. [PMID: 31148112 DOI: 10.1007/978-1-4939-9528-8_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Chalmers SB, Monteith GR. ORAI channels and cancer. Cell Calcium 2018;74:160-7. [PMID: 30086406 DOI: 10.1016/j.ceca.2018.07.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
189 Zhang K, Wang L, Wei A, Jia X, Liu X. CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo. Thorac Cancer 2020;11:1566-77. [PMID: 32368855 DOI: 10.1111/1759-7714.13430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
190 Jin Y, Meng X, Qiu Z, Su Y, Yu P, Qu P. Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris. Saudi J Biol Sci 2018;25:991-5. [PMID: 30108453 DOI: 10.1016/j.sjbs.2018.05.016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
191 Liu Y, Paterson M, Baumgardt SL, Irwin MG, Xia Z, Bosnjak ZJ, Ge ZD. Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning. Cardiovasc Res 2019;115:168-78. [PMID: 29931049 DOI: 10.1093/cvr/cvy157] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
192 Zhong C, Li P, Argade S, Liu L, Chilla' A, Liang W, Xin H, Eliceiri B, Choudhury B, Ferrara N. Inhibition of protein glycosylation is a novel pro-angiogenic strategy that acts via activation of stress pathways. Nat Commun 2020;11:6330. [PMID: 33303737 DOI: 10.1038/s41467-020-20108-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Wang W, Zhang L, Xie Y, Zhen T, Su G, Zang Q. Fatal hemoptysis in patients with advanced esophageal cancer treated with apatinib. Onco Targets Ther. 2018;11:2565-2570. [PMID: 29765235 DOI: 10.2147/ott.s150555] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
194 Jacobs CL, Badiee RK, Lin MZ. StaPLs: versatile genetically encoded modules for engineering drug-inducible proteins. Nat Methods 2018;15:523-6. [PMID: 29967496 DOI: 10.1038/s41592-018-0041-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
195 Fallah A, Sadeghinia A, Kahroba H, Samadi A, Heidari HR, Bradaran B, Zeinali S, Molavi O. Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases. Biomed Pharmacother 2019;110:775-85. [PMID: 30554116 DOI: 10.1016/j.biopha.2018.12.022] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 23.7] [Reference Citation Analysis]
196 Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol 2018;135:311-36. [PMID: 29411111 DOI: 10.1007/s00401-018-1815-1] [Cited by in Crossref: 224] [Cited by in F6Publishing: 214] [Article Influence: 74.7] [Reference Citation Analysis]
197 Yang Z, Yao J, Wang J, Zhang C, Cao Y, Hao L, Yang C, Wu C, Zhang J, Wang Z, Ran H, Tian Y. Ferrite-encapsulated nanoparticles with stable photothermal performance for multimodal imaging-guided atherosclerotic plaque neovascularization therapy. Biomater Sci 2021;9:5652-64. [PMID: 34259244 DOI: 10.1039/d1bm00343g] [Reference Citation Analysis]
198 Zhang S, Zhang R, Xu R, Shang J, He H, Yang Q. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3). Gene 2020;733:144383. [PMID: 31972307 DOI: 10.1016/j.gene.2020.144383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
199 Li W, Pang IH, Pacheco MTF, Tian H. Ligandomics: a paradigm shift in biological drug discovery. Drug Discov Today 2018;23:636-43. [PMID: 29326083 DOI: 10.1016/j.drudis.2018.01.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
200 Santonocito M, Zappulla C, Viola S, La Rosa LR, Solfato E, Abbate I, Tarallo V, Apicella I, Platania CBM, Maugeri G, D'Agata V, Bucolo C, De Falco S, Mazzone MG, Giuliano F. Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye. Int J Mol Sci 2021;22:4404. [PMID: 33922399 DOI: 10.3390/ijms22094404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Mukherjee A, Madamsetty VS, Paul MK, Mukherjee S. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer. Int J Mol Sci 2020;21:E455. [PMID: 31936832 DOI: 10.3390/ijms21020455] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 24.0] [Reference Citation Analysis]
202 Zhang Y, He B, Liu K, Ning L, Luo D, Xu K, Zhu W, Wu Z, Huang J, Xu X. A novel peptide specifically binding to VEGF receptor suppresses angiogenesis in vitro and in vivo. Signal Transduct Target Ther 2017;2:17010. [PMID: 29263914 DOI: 10.1038/sigtrans.2017.10] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
203 Melegh Z, Oltean S. Targeting Angiogenesis in Prostate Cancer. Int J Mol Sci. 2019;20. [PMID: 31151317 DOI: 10.3390/ijms20112676] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
204 Liang C, Zhang X, Yang M, Wang W, Chen P, Dong X. Remodeling Tumor Microenvironment by Multifunctional Nanoassemblies for Enhanced Photodynamic Cancer Therapy. ACS Materials Lett 2020;2:1268-86. [DOI: 10.1021/acsmaterialslett.0c00259] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 13.0] [Reference Citation Analysis]
205 Karaman S, Leppänen V, Alitalo K. Vascular endothelial growth factor signaling in development and disease. Development 2018;145:dev151019. [DOI: 10.1242/dev.151019] [Cited by in Crossref: 110] [Cited by in F6Publishing: 99] [Article Influence: 36.7] [Reference Citation Analysis]
206 Hsieh HL, Tsai MM. Tumor progression-dependent angiogenesis in gastric cancer and its potential application. World J Gastrointest Oncol 2019; 11(9): 686-704 [PMID: 31558974 DOI: 10.4251/wjgo.v11.i9.686] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
207 Bartneck M. Immunomodulatory Nanomedicine. Macromol Biosci 2017;17:1700021. [DOI: 10.1002/mabi.201700021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
208 Krüger K, Silwal-Pandit L, Wik E, Straume O, Stefansson IM, Borgen E, Garred Ø, Naume B, Engebraaten O, Akslen LA. Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. Sci Rep 2021;11:3388. [PMID: 33564016 DOI: 10.1038/s41598-021-81914-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Versmissen J, Mirabito Colafella KM, Koolen SLW, Danser AHJ. Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension. Cardiovasc Res 2019;115:904-14. [PMID: 30726882 DOI: 10.1093/cvr/cvz022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
210 Andreuzzi E, Fejza A, Capuano A, Poletto E, Pivetta E, Doliana R, Pellicani R, Favero A, Maiero S, Fornasarig M, Cannizzaro R, Iozzo RV, Spessotto P, Mongiat M. Deregulated expression of Elastin Microfibril Interfacer 2 (EMILIN2) in gastric cancer affects tumor growth and angiogenesis. Matrix Biol Plus 2020;6-7:100029. [PMID: 33543026 DOI: 10.1016/j.mbplus.2020.100029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
211 Liu G, Wang C, He Y, E M. Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours. BMC Pharmacol Toxicol 2019;20:61. [PMID: 31661009 DOI: 10.1186/s40360-019-0362-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
212 Wu Q, Xu S, Wang F, He B, Wang X, Sun Y, Ning C, Dai K. Double-edged effects caused by magnesium ions and alkaline environment regulate bioactivities of magnesium-incorporated silicocarnotite in vitro. Regen Biomater 2021;8:rbab016. [PMID: 34484805 DOI: 10.1093/rb/rbab016] [Reference Citation Analysis]
213 Majewska A, Wilkus K, Brodaczewska K, Kieda C. Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies. Int J Mol Sci 2021;22:E520. [PMID: 33430201 DOI: 10.3390/ijms22020520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
214 Tamucci KA, Namwanje M, Fan L, Qiang L. The dark side of browning. Protein Cell 2018;9:152-63. [PMID: 28677104 DOI: 10.1007/s13238-017-0434-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
215 Dubinski D, Hattingen E, Senft C, Seifert V, Peters KG, Reiss Y, Devraj K, Plate KH. Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies. J Cereb Blood Flow Metab 2019;39:1460-8. [PMID: 31238763 DOI: 10.1177/0271678X19859847] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
216 Park W, Baek YY, Kim J, Jo DH, Choi S, Kim JH, Kim T, Kim S, Park M, Kim JY, Won MH, Ha KS, Kim JH, Kwon YG, Kim YM. Arg-Leu-Tyr-Glu Suppresses Retinal Endothelial Permeability and Choroidal Neovascularization by Inhibiting the VEGF Receptor 2 Signaling Pathway. Biomol Ther (Seoul) 2019;27:474-83. [PMID: 31042676 DOI: 10.4062/biomolther.2019.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
217 Wang XR, Wang S, Li WB, Xu KY, Qiao XP, Jing XL, Wang ZX, Yang CJ, Chen SW. Design, synthesis and biological evaluation of novel 2-(4-(1H-indazol-6-yl)-1H-pyrazol-1-yl)acetamide derivatives as potent VEGFR-2 inhibitors. Eur J Med Chem 2021;213:113192. [PMID: 33493829 DOI: 10.1016/j.ejmech.2021.113192] [Reference Citation Analysis]
218 Grant ZL, Hickey PF, Abeysekera W, Whitehead L, Lewis SM, Symons RCA, Baldwin TM, Amann-Zalcenstein D, Garnham AL, Smyth GK, Thomas T, Voss AK, Coultas L. The histone acetyltransferase HBO1 promotes efficient tip cell sprouting during angiogenesis. Development 2021;148:dev199581. [PMID: 34550360 DOI: 10.1242/dev.199581] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Akgün M, Kemal Sezgintürk M. A novel biosensing system based on ITO-single use electrode for highly sensitive analysis of VEGF. International Journal of Environmental Analytical Chemistry 2020;100:432-50. [DOI: 10.1080/03067319.2019.1709637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
220 Cha S, Seo WI, Woo HN, Kim HJ, Lee SHS, Kim J, Choi JS, Park K, Lee JY, Lee BJ, Lee H. AAV expressing an mTOR-inhibiting siRNA exhibits therapeutic potential in retinal vascular disorders by preserving endothelial integrity. FEBS Open Bio 2021. [PMID: 34431239 DOI: 10.1002/2211-5463.13281] [Reference Citation Analysis]
221 Ferrara D, Newton EM, Lee AY. Artificial intelligence-based predictions in neovascular age-related macular degeneration. Curr Opin Ophthalmol 2021;32:389-96. [PMID: 34265783 DOI: 10.1097/ICU.0000000000000782] [Reference Citation Analysis]
222 Lennikov A, Mirabelli P, Mukwaya A, Schaupper M, Thangavelu M, Lachota M, Ali Z, Jensen L, Lagali N. Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis. Angiogenesis 2018;21:267-85. [PMID: 29332242 DOI: 10.1007/s10456-018-9594-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
223 Bhattarai P, Hameed S, Dai Z. Recent advances in anti-angiogenic nanomedicines for cancer therapy. Nanoscale 2018;10:5393-423. [DOI: 10.1039/c7nr09612g] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 11.3] [Reference Citation Analysis]
224 Li Q, Zhou R, Sun Y, Xiao D, Liu M, Zhao D, Peng S, Chen Y, Lin Y. Synthesis and Antitumor Application of Antiangiogenetic Gold Nanoclusters. ACS Appl Mater Interfaces 2021;13:11708-20. [PMID: 33656845 DOI: 10.1021/acsami.1c01164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Luengas-Martinez A, Hardman-Smart J, Paus R, Young HS. Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis. Exp Dermatol 2020;29:687-98. [PMID: 32654325 DOI: 10.1111/exd.14151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
226 Di N, Yao C, Cheng W, Ren Y, Qu J, Wang B, Yao Z. Correlation of dynamic contrast-enhanced MRI derived volume transfer constant with histological angiogenic markers in high-grade gliomas. J Med Imaging Radiat Oncol 2018. [PMID: 29330968 DOI: 10.1111/1754-9485.12701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
227 Deng C, Guo H, Yan D, Liang T, Ye X, Li Z. Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma. Biomed Res Int 2021;2021:5546612. [PMID: 33937395 DOI: 10.1155/2021/5546612] [Reference Citation Analysis]
228 Liu P, Ryczko M, Xie X, Baardsnes J, Lord-Dufour S, Duroche Y, Hicks EA, Taiyab A, Sheardown H, Quaggin SE, Jin J. New soluble angiopoietin analog of Hepta-ANG1 prevents pathological vascular leakage. Biotechnol Bioeng 2021;118:423-32. [PMID: 32970320 DOI: 10.1002/bit.27580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
229 Xin H, Zhong C, Nudleman E, Ferrara N. Evidence for Pro-angiogenic Functions of VEGF-Ax. Cell. 2016;167:275-284.e6. [PMID: 27662093 DOI: 10.1016/j.cell.2016.08.054] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
230 Shen F, Shi L, Wang Z, Wang C, Chen J, Liu Y, Qiu H, Zhu H. Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors. Bioorganic & Medicinal Chemistry 2019;27:3813-24. [DOI: 10.1016/j.bmc.2019.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
231 Shen CC, Cheng WY, Lee CH, Dai XJ, Chiao MT, Liang YJ, Hsieh WY, Mao TF, Lin GS, Chen SR, Liu BS, Chen JP. Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment. BMC Cancer 2020;20:709. [PMID: 32727419 DOI: 10.1186/s12885-020-07210-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
232 Albonici L, Giganti MG, Modesti A, Manzari V, Bei R. Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression. Int J Mol Sci 2019;20:E2970. [PMID: 31216652 DOI: 10.3390/ijms20122970] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
233 Chen YC, Chung CC, Lin YK, Chen YJ. Genetic and ethnic modulation of cardiovascular toxicity of vascular endothelial growth factor inhibitors. Ann Med 2018;50:46-56. [PMID: 28929822 DOI: 10.1080/07853890.2017.1383629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
234 Zhou J, Li M, Hou Y, Luo Z, Chen Q, Cao H, Huo R, Xue C, Sutrisno L, Hao L, Cao Y, Ran H, Lu L, Li K, Cai K. Engineering of a Nanosized Biocatalyst for Combined Tumor Starvation and Low-Temperature Photothermal Therapy. ACS Nano 2018;12:2858-72. [DOI: 10.1021/acsnano.8b00309] [Cited by in Crossref: 187] [Cited by in F6Publishing: 174] [Article Influence: 62.3] [Reference Citation Analysis]
235 Jin L, Han C, Zhai T, Zhang X, Chen C, Lian L. Circ_0030998 promotes tumor proliferation and angiogenesis by sponging miR-567 to regulate VEGFA in colorectal cancer. Cell Death Discov 2021;7:160. [PMID: 34226531 DOI: 10.1038/s41420-021-00544-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
236 Dzobo K, Dandara C. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance. OMICS 2020;24:314-39. [PMID: 32496970 DOI: 10.1089/omi.2020.0023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
237 Hu Y, Chen Y, Wang J, Kang JJ, Shen DD, Jia ZZ. Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI. Front Oncol 2020;10:593102. [PMID: 33425744 DOI: 10.3389/fonc.2020.593102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Arias-Pinilla GA, Modjtahedi H. Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities. Cancers (Basel) 2021;13:1781. [PMID: 33917882 DOI: 10.3390/cancers13081781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Shin D, Lee YJ, Choi J, Lee D, Park M, Petkova M. A phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers. Cancer Chemother Pharmacol 2020;86:567-75. [PMID: 32949267 DOI: 10.1007/s00280-020-04144-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
240 Wilkinson-Berka JL, Deliyanti D. The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies. Ann Transl Med 2016;4:S41. [PMID: 27868009 DOI: 10.21037/atm.2016.10.27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
241 Taghipour-sabzevar V, Sharifi T, Moghaddam MM. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents. Therapeutic Delivery 2019;10:527-50. [DOI: 10.4155/tde-2019-0044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
242 Lowery CD, Blosser W, Dowless M, Renschler M, Perez LV, Stephens J, Pytowski B, Wasserstrom H, Stancato LF, Falcon B. Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy. Oncotarget 2019;10:5523-33. [PMID: 31565186 DOI: 10.18632/oncotarget.27148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
243 Wen Z, Shen Y, Berry G, Shahram F, Li Y, Watanabe R, Liao YJ, Goronzy JJ, Weyand CM. The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway. Sci Transl Med 2017;9:eaal3322. [PMID: 28724574 DOI: 10.1126/scitranslmed.aal3322] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 14.0] [Reference Citation Analysis]
244 Yamamura A, Nayeem MJ, Muramatsu H, Nakamura K, Sato M. MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3. Front Pharmacol 2021;12:667474. [PMID: 33959030 DOI: 10.3389/fphar.2021.667474] [Reference Citation Analysis]
245 Kangsamaksin T, Chaithongyot S, Wootthichairangsan C, Hanchaina R, Tangshewinsirikul C, Svasti J. Lupeol and stigmasterol suppress tumor angiogenesis and inhibit cholangiocarcinoma growth in mice via downregulation of tumor necrosis factor-α. PLoS One 2017;12:e0189628. [PMID: 29232409 DOI: 10.1371/journal.pone.0189628] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
246 Claesson-Welsh L, Dejana E, McDonald DM. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies. Trends Mol Med 2021;27:314-31. [PMID: 33309601 DOI: 10.1016/j.molmed.2020.11.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
247 Saxena M, Bhardwaj N. Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment. Trends Cancer. 2018;4:119-137. [PMID: 29458962 DOI: 10.1016/j.trecan.2017.12.007] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 39.0] [Reference Citation Analysis]
248 Yao MD, Jiang Q, Ma Y, Liu C, Zhu CY, Sun YN, Shan K, Ge HM, Zhang QY, Zhang HY, Yao J, Li XM, Yan B. Role of METTL3-Dependent N6-Methyladenosine mRNA Modification in the Promotion of Angiogenesis. Mol Ther 2020;28:2191-202. [PMID: 32755566 DOI: 10.1016/j.ymthe.2020.07.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
249 Li Y, Cai Y, Huang Q, Tan W, Li B, Zhou H, Wang Z, Zou J, Ding C, Jiang B, Yoshida S, Zhou Y. Altered Fecal Microbiome and Metabolome in a Mouse Model of Choroidal Neovascularization. Front Microbiol 2021;12:738796. [PMID: 34512615 DOI: 10.3389/fmicb.2021.738796] [Reference Citation Analysis]
250 Schneider M, Angele P, Järvinen TAH, Docheva D. Rescue plan for Achilles: Therapeutics steering the fate and functions of stem cells in tendon wound healing. Adv Drug Deliv Rev 2018;129:352-75. [PMID: 29278683 DOI: 10.1016/j.addr.2017.12.016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 12.5] [Reference Citation Analysis]
251 Li AM, Boichard A, Kurzrock R. Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues. Cancer Biol Ther 2020;21:95-100. [PMID: 31564192 DOI: 10.1080/15384047.2019.1665956] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
252 Haumann R, Videira JC, Kaspers GJL, van Vuurden DG, Hulleman E. Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors. CNS Drugs 2020;34:1121-31. [PMID: 32965590 DOI: 10.1007/s40263-020-00766-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
253 Zheng L, Zhao C, Du Y, Lin X, Jiang Y, Lee C, Tian G, Mi J, Li X, Chen Q, Ye Z, Huang L, Wang S, Ren X, Xing L, Chen W, Huang D, Gao Z, Zhang S, Lu W, Tang Z, Wang B, Ju R, Li X. PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently. Oncotarget 2016;7:77902-15. [PMID: 27788490 DOI: 10.18632/oncotarget.12843] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
254 Zhang Y, Sun M, Huang G, Yin L, Lai Q, Yang Y, Xing X, Yu G, Sun Y, Wang X, Nie G, Liu Y, Cao Y. Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy. Proc Natl Acad Sci U S A 2017;114:E5226-35. [PMID: 28607065 DOI: 10.1073/pnas.1705066114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
255 De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer 2017;17:457-74. [DOI: 10.1038/nrc.2017.51] [Cited by in Crossref: 643] [Cited by in F6Publishing: 636] [Article Influence: 160.8] [Reference Citation Analysis]
256 Zhuo Z, Yu Y, Wang M, Li J, Zhang Z, Liu J, Wu X, Lu A, Zhang G, Zhang B. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine. Int J Mol Sci. 2017;18:pii: E2142. [PMID: 29036890 DOI: 10.3390/ijms18102142] [Cited by in Crossref: 142] [Cited by in F6Publishing: 114] [Article Influence: 35.5] [Reference Citation Analysis]
257 Kumar K, Ghosh A. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124. Molecules 2021;26:E414. [PMID: 33466827 DOI: 10.3390/molecules26020414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
258 Pei D, Hu J, Rao C, Yu P, Xu H, Wang J. Anti-Tumor Activity and Pharmacokinetics of AP25-Fc Fusion Protein. Int J Med Sci 2019;16:1032-41. [PMID: 31341417 DOI: 10.7150/ijms.34365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Chillà A, Margheri F, Biagioni A, Del Rosso M, Fibbi G, Laurenzana A. Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis. J Exp Clin Cancer Res 2018;37:74. [PMID: 29615071 DOI: 10.1186/s13046-018-0742-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
260 Ghinea N. Anti-Angiogenic Therapy: Albumin-Binding Proteins Could Mediate Mechanisms Underlying the Accumulation of Small Molecule Receptor Tyrosine Kinase Inhibitors in Normal Tissues with Potential Harmful Effects on Health. Diseases 2021;9:28. [PMID: 33920299 DOI: 10.3390/diseases9020028] [Reference Citation Analysis]
261 Šošić L, Selbo PK, Kotkowska ZK, Kündig TM, Høgset A, Johansen P. Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines. Cancers (Basel) 2020;12:E165. [PMID: 31936595 DOI: 10.3390/cancers12010165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
262 Paul MD, Hristova K. The RTK Interactome: Overview and Perspective on RTK Heterointeractions. Chem Rev 2019;119:5881-921. [PMID: 30589534 DOI: 10.1021/acs.chemrev.8b00467] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
263 Azad R, Gilbert C, Gangwe AB, Zhao P, Wu W, Sarbajna P, Vinekar A. Retinopathy of Prematurity: How to Prevent the Third Epidemics in Developing Countries. Asia-Pacific Journal of Ophthalmology 2020;9:440-8. [DOI: 10.1097/apo.0000000000000313] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
264 Monés J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, Holz FG, Korobelnik JF, Kim IK, Pruente C, Murray TG, Heier JS. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER. Ophthalmology 2021;128:1050-9. [PMID: 33207259 DOI: 10.1016/j.ophtha.2020.11.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 24.0] [Reference Citation Analysis]
265 Riesco-Martinez M, Parra K, Saluja R, Francia G, Emmenegger U. Resistance to metronomic chemotherapy and ways to overcome it. Cancer Lett 2017;400:311-8. [PMID: 28259819 DOI: 10.1016/j.canlet.2017.02.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
266 Chandler KB, Costello CE, Rahimi N. Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis. Cells 2019;8:E544. [PMID: 31195728 DOI: 10.3390/cells8060544] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
267 Yin X, Lin X, Ren X, Yu B, Liu L, Ye Z, Chen Q, Lee C, Lu W, Yu D, Li X. Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene sets. Pharmacol Res 2019;146:104277. [PMID: 31112749 DOI: 10.1016/j.phrs.2019.104277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
268 Tang R, Xian D, Xu J, Peng H, Pan S, Zhong J. Proanthocyanidins as a Potential Novel Way for the Treatment of Hemangioma. Biomed Res Int 2021;2021:5695378. [PMID: 33490272 DOI: 10.1155/2021/5695378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Corti F, Simons M. Modulation of VEGF receptor 2 signaling by protein phosphatases. Pharmacol Res 2017;115:107-23. [PMID: 27888154 DOI: 10.1016/j.phrs.2016.11.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
270 Li X, Redfors B, Sáinz-Jaspeado M, Shi S, Martinsson P, Padhan N, Scharin Täng M, Borén J, Levin M, Claesson-Welsh L. Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction. Front Physiol 2020;11:763. [PMID: 32733273 DOI: 10.3389/fphys.2020.00763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
271 Singhal M, Gengenbacher N, La Porta S, Gehrs S, Shi J, Kamiyama M, Bodenmiller DM, Fischl A, Schieb B, Besemfelder E, Chintharlapalli S, Augustin HG. Preclinical validation of a novel metastasis-inhibiting Tie1 function-blocking antibody. EMBO Mol Med 2020;12:e11164. [PMID: 32302470 DOI: 10.15252/emmm.201911164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
272 Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov 2017;16:635-61. [PMID: 28529319 DOI: 10.1038/nrd.2016.278] [Cited by in Crossref: 176] [Cited by in F6Publishing: 161] [Article Influence: 44.0] [Reference Citation Analysis]
273 Faes S, Santoro T, Demartines N, Dormond O. Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy. Cancers (Basel) 2017;9:E152. [PMID: 29104248 DOI: 10.3390/cancers9110152] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
274 Chen WZ, Jiang JX, Yu XY, Xia WJ, Yu PX, Wang K, Zhao ZY, Chen ZG. Endothelial cells in colorectal cancer. World J Gastrointest Oncol 2019; 11(11): 946-956 [PMID: 31798776 DOI: 10.4251/wjgo.v11.i11.946] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
275 Wang YZ, Ngowi EE, Wang D, Qi HW, Jing MR, Zhang YX, Cai CB, He QL, Khattak S, Khan NH, Jiang QY, Ji XY, Wu DD. The Potential of Hydrogen Sulfide Donors in Treating Cardiovascular Diseases. Int J Mol Sci 2021;22:2194. [PMID: 33672103 DOI: 10.3390/ijms22042194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
276 Wentink MQ, Broxterman HJ, Lam SW, Boven E, Walraven M, Griffioen AW, Pili R, van der Vliet HJ, de Gruijl TD, Verheul HM. A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer. Br J Cancer 2016;115:940-8. [PMID: 27575850 DOI: 10.1038/bjc.2016.275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
277 Mirshahi A, Lashay A, Riazi-Esfahani H, Ebrahimiadib N, Khojasteh H, Ghassemi F, Bazvand F, Khodabande A, Roohipour R, Pour EK, Faghihi H. Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series. J Ophthalmic Vis Res 2021;16:28-33. [PMID: 33520125 DOI: 10.18502/jovr.v16i1.8248] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
278 Liang X, Zang J, Li X, Tang S, Huang M, Geng M, Chou CJ, Li C, Cao Y, Xu W, Liu H, Zhang Y. Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies. J Med Chem 2019;62:3898-923. [DOI: 10.1021/acs.jmedchem.8b01597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
279 Surowka M, Schaefer W, Klein C. Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins. MAbs 2021;13:1967714. [PMID: 34491877 DOI: 10.1080/19420862.2021.1967714] [Reference Citation Analysis]
280 Zou H, Wei Z, Song C, Ran J, Cao Z, Tang C, Zhang G, Cai Y, Lu M, Han W. Novel NIR-II semiconducting molecule incorporating sorafenib for imaging guided synergetic cancer phototherapy and anti-angiogenic therapy. J Mater Chem B 2021;9:3235-48. [PMID: 33885627 DOI: 10.1039/d1tb00209k] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
281 Li J, Li Z, Wang C, Li Z, Xu H, Hu Y, Tan Z, Zhang F, Liu C, Yang M, Wang Y, Jin Y, Peng Z, Biswas S, Zhu L. The Regulatory Effect of VEGF-Ax on Rat Bone Marrow Mesenchymal Stem Cells' Angioblastic Differentiation and Its Proangiogenic Ability. Stem Cells and Development 2020;29:667-77. [DOI: 10.1089/scd.2019.0198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
282 Le X, Nilsson M, Goldman J, Reck M, Nakagawa K, Kato T, Ares LP, Frimodt-moller B, Wolff K, Visseren-grul C, Heymach JV, Garon EB. Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC. Journal of Thoracic Oncology 2021;16:205-15. [DOI: 10.1016/j.jtho.2020.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
283 Jing Y, Chavez V, Ban Y, Acquavella N, El-Ashry D, Pronin A, Chen X, Merchan JR. Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer. Mol Cancer Res 2017;15:1410-20. [PMID: 28679779 DOI: 10.1158/1541-7786.MCR-17-0016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
284 Xu W, Hua H, Chiu YH, Li G, Zhi H, Yu Z, Ren F, Luo Y, Cui W. CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of the PI3K and mTORC1 Pathways. Cell Rep 2019;29:1311-1322.e5. [PMID: 31665642 DOI: 10.1016/j.celrep.2019.09.047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
285 Kumar Kulabhusan P, Hussain B, Yüce M. Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents. Pharmaceutics 2020;12:E646. [PMID: 32659966 DOI: 10.3390/pharmaceutics12070646] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 23.0] [Reference Citation Analysis]
286 Nyström L, Malmsten M. Membrane interactions and cell selectivity of amphiphilic anticancer peptides. Current Opinion in Colloid & Interface Science 2018;38:1-17. [DOI: 10.1016/j.cocis.2018.06.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
287 Lin Y, Ren X, Chen Y, Chen D. Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment. Front Neurosci 2020;14:617377. [PMID: 33551729 DOI: 10.3389/fnins.2020.617377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
288 Schito L. Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment. Am J Physiol Regul Integr Comp Physiol 2018;315:R1072-84. [PMID: 30183339 DOI: 10.1152/ajpregu.00209.2018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
289 Mao Z, Xu B, He L, Zhang G. PVT1 Promotes Angiogenesis by Regulating miR-29c/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway in Non-Small-Cell Lung Cancer (NSCLC). Med Sci Monit 2019;25:5418-25. [PMID: 31326971 DOI: 10.12659/MSM.917601] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
290 De Simone G. Targeted treatment of anaerobic cancer. Patent evaluation of US2016279084 and US2017056350. Expert Opin Ther Pat 2019;29:1-6. [PMID: 30556445 DOI: 10.1080/13543776.2019.1558210] [Reference Citation Analysis]
291 Xue R, Chen M, Cai J, Deng Z, Pan D, Liu X, Li Y, Rong X, Li H, Xu Y, Shen Q, Tang Y. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study. Front Oncol 2021;11:720417. [PMID: 34692494 DOI: 10.3389/fonc.2021.720417] [Reference Citation Analysis]
292 Ogier C, Colombo PE, Bousquet C, Canterel-Thouennon L, Sicard P, Garambois V, Thomas G, Gaborit N, Jarlier M, Pirot N. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Lett. 2018;432:227-236. [PMID: 29935372 DOI: 10.1016/j.canlet.2018.06.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
293 Ding SLS, Kumar S, Mok PL. Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases. Int J Mol Sci. 2017;18. [PMID: 28788088 DOI: 10.3390/ijms18081406] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
294 Simonetti O, Cirioni O, Goteri G, Lucarini G, Kamysz E, Kamysz W, Orlando F, Rizzetto G, Molinelli E, Morroni G, Ghiselli R, Provinciali M, Giacometti A, Offidani A. Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model. Antibiotics (Basel) 2021;10:1210. [PMID: 34680791 DOI: 10.3390/antibiotics10101210] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Ji X, Wang H, Chen Y, Zhou J, Liu Y. Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood-brain barrier and target glioma. AMB Express 2019;9:165. [PMID: 31617104 DOI: 10.1186/s13568-019-0869-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
296 Noueihed B, Rivera JC, Dabouz R, Abram P, Omri S, Lahaie I, Chemtob S. Mesenchymal Stromal Cells Promote Retinal Vascular Repair by Modulating Sema3E and IL-17A in a Model of Ischemic Retinopathy. Front Cell Dev Biol 2021;9:630645. [PMID: 33553187 DOI: 10.3389/fcell.2021.630645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
297 Miyamoto D, Sotto MN, Otani CS, Fukumori LM, Pereira NV, Santi CG, Maruta CW, Burnier MN, Rebeis MM, Aoki V. Increased serum levels of vascular endothelial growth factor in pemphigus foliaceus patients with erythroderma. J Eur Acad Dermatol Venereol 2017;31:333-6. [PMID: 27510449 DOI: 10.1111/jdv.13905] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
298 Liang LJ, Wen YX, Xia YY, Wang L, Fei JY, Jiang XD. Apatinib combined with docetaxel as a salvage treatment for metastatic esophageal squamous cancer: a case report. Onco Targets Ther 2018;11:5821-6. [PMID: 30271164 DOI: 10.2147/OTT.S174429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
299 Liu G, Chen T, Ding Z, Wang Y, Wei Y, Wei X. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment. Cell Prolif 2021;54:e13009. [PMID: 33655556 DOI: 10.1111/cpr.13009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
300 Upshaw JN. Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review. Curr Oncol Rep 2020;22. [DOI: 10.1007/s11912-020-00923-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
301 Chen W, Ma Y, Pan G. Synthetic Receptors With Bioaffinity for Biomedical Applications. Theranostic Bionanomaterials. Elsevier; 2019. pp. 113-42. [DOI: 10.1016/b978-0-12-815341-3.00005-5] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
302 Yan Y, Yan Q, Qian L, Jiang Y, Chen X, Zeng S, Xu Z, Gong Z. S-adenosylmethionine administration inhibits levodopa-induced vascular endothelial growth factor-A expression. Aging (Albany NY) 2020;12:21290-307. [PMID: 33170152 DOI: 10.18632/aging.103863] [Reference Citation Analysis]
303 Renfrow JJ, Soike MH, Debinski W, Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ, Strowd RE. Hypoxia-inducible factor 2α: a novel target in gliomas. Future Med Chem 2018;10:2227-36. [PMID: 30089425 DOI: 10.4155/fmc-2018-0163] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
304 Aouiss A, Anka Idrissi D, Kabine M, Zaid Y. Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis. Curr Res Transl Med. 2019;67:62-71. [PMID: 30685380 DOI: 10.1016/j.retram.2019.01.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
305 Cavalcanti E, Ignazzi A, De Michele F, Caruso ML. PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors. Cancer Biol Ther 2019;20:423-30. [PMID: 30346879 DOI: 10.1080/15384047.2018.1529114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
306 Tang M, Ji X, Xu H, Zhang L, Jiang A, Song B, Su Y, He Y. Photostable and Biocompatible Fluorescent Silicon Nanoparticles-Based Theranostic Probes for Simultaneous Imaging and Treatment of Ocular Neovascularization. Anal Chem 2018;90:8188-95. [PMID: 29874038 DOI: 10.1021/acs.analchem.8b01580] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
307 Xiong C, Mao Y, Wu T, Kang N, Zhao M, Di R, Li X, Ji X, Liu Y. Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in Pichia pastoris and Evaluation of Antitumor Activity In Vivo. Int J Mol Sci 2018;19:E2900. [PMID: 30257416 DOI: 10.3390/ijms19102900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
308 Choudhary S, Doshi A, Luckett-Chastain L, Ihnat M, Hamel E, Mooberry SL, Gangjee A. Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer. Bioorg Med Chem 2021;35:116061. [PMID: 33647840 DOI: 10.1016/j.bmc.2021.116061] [Reference Citation Analysis]
309 Visvikis-Siest S, Theodoridou D, Kontoe MS, Kumar S, Marschler M. Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.Front Genet. 2020;11:569175. [PMID: 33424917 DOI: 10.3389/fgene.2020.569175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Esfandiarpour-boroujeni S, Bagheri-khoulenjani S, Mirzadeh H, Amanpour S. Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application. Carbohydrate Polymers 2017;168:14-21. [DOI: 10.1016/j.carbpol.2017.03.031] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 16.5] [Reference Citation Analysis]
311 Reddy VG, Reddy TS, Jadala C, Reddy MS, Sultana F, Akunuri R, Bhargava SK, Wlodkowic D, Srihari P, Kamal A. Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model. European Journal of Medicinal Chemistry 2019;182:111609. [DOI: 10.1016/j.ejmech.2019.111609] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
312 Xin H, Biswas N, Li P, Zhong C, Chan TC, Nudleman E, Ferrara N. Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders. Proc Natl Acad Sci U S A 2021;118:e1921252118. [PMID: 34006633 DOI: 10.1073/pnas.1921252118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
313 Bisht R, Nirmal S, Agrawal R, Jain GK, Nirmal J. Injectable in-situ gel depot system for targeted delivery of biologics to the retina. J Drug Target 2021;29:46-59. [PMID: 32729731 DOI: 10.1080/1061186X.2020.1803886] [Reference Citation Analysis]
314 Vincent MD. Cancer: Towards a general theory of the target: All successful cancer therapies, actual or potential, are reducible to either (or both) of two fundamental strategies. BioEssays 2017;39:1700059. [DOI: 10.1002/bies.201700059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
315 Silva JAF, Qi X, Grant MB, Boulton ME. Spatial and temporal VEGF receptor intracellular trafficking in microvascular and macrovascular endothelial cells. Sci Rep 2021;11:17400. [PMID: 34462507 DOI: 10.1038/s41598-021-96964-7] [Reference Citation Analysis]
316 Song J, Lee JW, Chung SH, Wenas MA, Min KH. Structure-Activity Relationship of 4,6-Disubstituted Pyrimidines as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors. Bull Korean Chem Soc 2017;38:1255-6. [DOI: 10.1002/bkcs.11278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
317 Bakhman A, Rabinovich E, Shlamkovich T, Papo N, Kosloff M. Residue-level determinants of angiopoietin-2 interactions with its receptor Tie2. Proteins 2019;87:185-97. [PMID: 30520519 DOI: 10.1002/prot.25638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
318 Huang L, Jiang S, Shi Y. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020). J Hematol Oncol 2020;13:143. [PMID: 33109256 DOI: 10.1186/s13045-020-00977-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
319 Nuti E, Bassani B, Camodeca C, Rosalia L, Cantelmo A, Gallo C, Baci D, Bruno A, Orlandini E, Nencetti S, Noonan DM, Albini A, Rossello A. Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues. Eur J Med Chem 2017;138:890-9. [PMID: 28750311 DOI: 10.1016/j.ejmech.2017.07.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
320 Waliany S, Sainani KL, Park LS, Zhang CA, Srinivas S, Witteles RM. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor. JACC CardioOncol 2019;1:24-36. [PMID: 34396159 DOI: 10.1016/j.jaccao.2019.08.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
321 Herrmann A, Nagao T, Zhang C, Lahtz C, Li YJ, Yue C, Mülfarth R, Yu H. An effective cell-penetrating antibody delivery platform. JCI Insight 2019;4:127474. [PMID: 31341104 DOI: 10.1172/jci.insight.127474] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
322 Supe S, Upadhya A, Singh K. Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review. Exp Eye Res. 2021;202:108329. [PMID: 33198953 DOI: 10.1016/j.exer.2020.108329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
323 Kabir AU, Subramanian M, Lee DH, Wang X, Krchma K, Wu J, Naismith T, Halabi CM, Kim JY, Pulous FE, Petrich BG, Kim S, Park HC, Hanson PI, Pan H, Wickline SA, Fremont DH, Park C, Choi K. Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity. Sci Transl Med 2021;13:eabb6731. [PMID: 33658356 DOI: 10.1126/scitranslmed.abb6731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
324 Peng F, Liu D, Zhang Q, Xu Y, Shi L. VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016). Expert Opinion on Therapeutic Patents 2017;27:987-1004. [DOI: 10.1080/13543776.2017.1344215] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
325 Zhang X, Wang Y, Fan J, Chen W, Luan J, Mei X, Wang S, Li Y, Ye L, Li S, Tian W, Yin K, Ju D. Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer. J Immunother Cancer 2019;7:346. [PMID: 31829270 DOI: 10.1186/s40425-019-0812-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
326 Peach CJ, Kilpatrick LE, Friedman-Ohana R, Zimmerman K, Robers MB, Wood KV, Woolard J, Hill SJ. Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells. Cell Chem Biol 2018;25:1208-1218.e5. [PMID: 30057299 DOI: 10.1016/j.chembiol.2018.06.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
327 Tsiros D, Sheehy CE, Pecchia S, Nugent MA. Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH. J Biol Chem 2019;294:17603-11. [PMID: 31601651 DOI: 10.1074/jbc.RA119.009194] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
328 Wang YS, Chen C, Zhang SY, Li Y, Jin YH. (20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2. Int J Mol Sci 2021;22:9289. [PMID: 34502195 DOI: 10.3390/ijms22179289] [Reference Citation Analysis]
329 Bai Y, Wang Y, Zhang X, Fu J, Xing X, Wang C, Gao L, Liu Y, Shi L. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy. Int J Pharm 2019;570:118636. [PMID: 31446027 DOI: 10.1016/j.ijpharm.2019.118636] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
330 Schmittnaegel M, Rigamonti N, Kadioglu E, Cassará A, Wyser Rmili C, Kiialainen A, Kienast Y, Mueller HJ, Ooi CH, Laoui D, De Palma M. Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade. Sci Transl Med 2017;9:eaak9670. [PMID: 28404865 DOI: 10.1126/scitranslmed.aak9670] [Cited by in Crossref: 241] [Cited by in F6Publishing: 224] [Article Influence: 60.3] [Reference Citation Analysis]
331 Almobarak AA, Jebreel AB, Abu-Zaid A. Molecular Targeted Therapy in the Management of Recurrent and Metastatic Nasopharyngeal Carcinoma: A Comprehensive Literature Review. Cureus 2019;11:e4210. [PMID: 31114729 DOI: 10.7759/cureus.4210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
332 Bae B, Kim H, Park H, Koh YJ, Bae SJ, Ha KT. Anti-Angiogenic Property of Free Human Oligosaccharides. Biomolecules 2021;11:775. [PMID: 34064180 DOI: 10.3390/biom11060775] [Reference Citation Analysis]
333 Heier JS, Singh RP, Wykoff CC, Csaky KG, Lai TYY, Loewenstein A, Schlottmann PG, Paris LP, Westenskow PD, Quezada-Ruiz C. THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review. Retina 2021;41:1-19. [PMID: 33136975 DOI: 10.1097/IAE.0000000000003003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
334 Wei W, Ehlerding EB, Lan X, Luo Q, Cai W. PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging 2018;45:132-50. [PMID: 29085965 DOI: 10.1007/s00259-017-3839-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
335 Chen J, Lin M, Che Y, Guo J, Lin W. Key genes in youth colorectal cancer based on data mining and verification by reverse transcription-quantitative PCR. Oncol Lett 2021;21:194. [PMID: 33574933 DOI: 10.3892/ol.2021.12455] [Reference Citation Analysis]
336 Apte RS, Chen DS, Ferrara N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176:1248-1264. [PMID: 30849371 DOI: 10.1016/j.cell.2019.01.021] [Cited by in Crossref: 352] [Cited by in F6Publishing: 357] [Article Influence: 352.0] [Reference Citation Analysis]
337 Khabbazi S, Nassar ZD, Goumon Y, Parat MO. Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro. Sci Rep 2016;6:31572. [PMID: 27514308 DOI: 10.1038/srep31572] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
338 Li T, Kang G, Wang T, Huang H. Tumor angiogenesis and anti-angiogenic gene therapy for cancer. Oncol Lett 2018;16:687-702. [PMID: 29963134 DOI: 10.3892/ol.2018.8733] [Cited by in Crossref: 27] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
339 Fortmann SD, Grant MB. Molecular mechanisms of retinal ischemia. Curr Opin Physiol 2019;7:41-8. [PMID: 34322649 DOI: 10.1016/j.cophys.2018.12.008] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
340 Cheng X, Zhang F, Li J, Wang G. Galuteolin attenuates cerebral ischemia/reperfusion injury in rats via anti-apoptotic, anti-oxidant, and anti-inflammatory mechanisms. Neuropsychiatr Dis Treat 2019;15:2671-80. [PMID: 31571883 DOI: 10.2147/NDT.S215263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
341 Hoeres T, Wilhelm M, Smetak M, Holzmann E, Schulze-Tanzil G, Birkmann J. Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1. Clin Exp Immunol 2018;192:54-67. [PMID: 29235095 DOI: 10.1111/cei.13090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
342 Haugen MH, Lingjærde OC, Hedenfalk I, Garred Ø, Borgen E, Loman N, Hatschek T, Børresen-Dale AL, Naume B, Mills GB, Mælandsmo GM, Engebraaten O. Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers. JCO Precis Oncol 2021;5:PO. [PMID: 34036235 DOI: 10.1200/PO.20.00086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
343 He MY, Halford MM, Liu R, Roy JP, Grant ZL, Coultas L, Thio N, Gilan O, Chan YC, Dawson MA, Achen MG, Stacker SA. Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapy. Commun Biol 2021;4:878. [PMID: 34267311 DOI: 10.1038/s42003-021-02397-3] [Reference Citation Analysis]
344 Mandal A, Pal D, Agrahari V, Trinh HM, Joseph M, Mitra AK. Ocular delivery of proteins and peptides: Challenges and novel formulation approaches. Adv Drug Deliv Rev 2018;126:67-95. [PMID: 29339145 DOI: 10.1016/j.addr.2018.01.008] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 23.0] [Reference Citation Analysis]
345 Kim CG, Jang M, Kim Y, Leem G, Kim KH, Lee H, Kim T, Choi SJ, Kim H, Han JW, Kwon M, Kim JH, Lee AJ, Nam SK, Bae S, Lee SB, Shin SJ, Park SH, Ahn JB, Jung I, Lee KY, Park S, Kim H, Min BS, Shin E. VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers. Sci Immunol 2019;4:eaay0555. [DOI: 10.1126/sciimmunol.aay0555] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 25.5] [Reference Citation Analysis]
346 Bazzazi H, Popel AS. Computational investigation of sphingosine kinase 1 (SphK1) and calcium dependent ERK1/2 activation downstream of VEGFR2 in endothelial cells. PLoS Comput Biol 2017;13:e1005332. [PMID: 28178265 DOI: 10.1371/journal.pcbi.1005332] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
347 Ferrara N. Microvascular Density as a Predictive Biomarker for Bevacizumab Survival Benefit in Ovarian Cancer: Back to First Principles? J Natl Cancer Inst 2017;109. [PMID: 29059427 DOI: 10.1093/jnci/djx067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
348 Hack SP, Zhu AX, Wang Y. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities. Front Immunol 2020;11:598877. [PMID: 33250900 DOI: 10.3389/fimmu.2020.598877] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
349 Tanigawa K, Maekawa M, Kiyoi T, Nakayama J, Kitazawa R, Kitazawa S, Semba K, Taguchi T, Akita S, Yoshida M, Ishimaru K, Watanabe Y, Higashiyama S. SNX9 determines the surface levels of integrin β1 in vascular endothelial cells: Implication in poor prognosis of human colorectal cancers overexpressing SNX9. J Cell Physiol 2019;234:17280-94. [PMID: 30784076 DOI: 10.1002/jcp.28346] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
350 Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology 2020;9:1777625. [PMID: 32934882 DOI: 10.1080/2162402X.2020.1777625] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 25.0] [Reference Citation Analysis]
351 Zhuang X, Zhang H, Hu G. Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis. Trends Pharmacol Sci 2019;40:419-29. [PMID: 31078320 DOI: 10.1016/j.tips.2019.04.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
352 Belotti D, Pinessi D, Taraboletti G. Alternative Vascularization Mechanisms in Tumor Resistance to Therapy. Cancers (Basel) 2021;13:1912. [PMID: 33921099 DOI: 10.3390/cancers13081912] [Reference Citation Analysis]
353 Niklander S, Bordagaray MJ, Fernández A, Hernández M. Vascular Endothelial Growth Factor: A Translational View in Oral Non-Communicable Diseases. Biomolecules 2021;11:85. [PMID: 33445558 DOI: 10.3390/biom11010085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
354 Wen S, Zhang K, Li Y, Fan J, Ziming C, Zhang J, Wang H, Wang L. A self-assembling peptide targeting VEGF receptors to inhibit angiogenesis. Chinese Chemical Letters 2020;31:3153-7. [DOI: 10.1016/j.cclet.2020.03.077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
355 Contarelli S, Fedele V, Melisi D. HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies. Cancers (Basel) 2020;12:E3299. [PMID: 33171691 DOI: 10.3390/cancers12113299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
356 Ngema LM, Adeyemi SA, Marimuthu T, Choonara YE. A review on engineered magnetic nanoparticles in Non-Small-Cell lung carcinoma targeted therapy. Int J Pharm 2021;606:120870. [PMID: 34245844 DOI: 10.1016/j.ijpharm.2021.120870] [Reference Citation Analysis]
357 Mabeta P. Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting. Int J Mol Sci 2018;19:E1192. [PMID: 29652858 DOI: 10.3390/ijms19041192] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
358 De Pascale MR, Della Mura N, Vacca M, Napoli C. Useful applications of growth factors for cardiovascular regenerative medicine. Growth Factors 2020;38:35-63. [PMID: 33028111 DOI: 10.1080/08977194.2020.1825410] [Reference Citation Analysis]
359 Lallemand C, Ferrando-Miguel R, Auer M, Iglseder S, Czech T, Gaber-Wagener A, Di Pauli F, Deisenhammer F, Tovey MG. Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma. Front Immunol 2020;11:515556. [PMID: 33178180 DOI: 10.3389/fimmu.2020.515556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
360 Allen E, Missiaen R, Bergers G. Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors. Oncotarget 2017;8:99207-8. [PMID: 29245888 DOI: 10.18632/oncotarget.22276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
361 Meng YM, Liang J, Wu C, Xu J, Zeng DN, Yu XJ, Ning H, Xu L, Zheng L. Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma. Oncoimmunology 2018;7:e1408745. [PMID: 29399411 DOI: 10.1080/2162402X.2017.1408745] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
362 Kang D, Pang X, Lian W, Xu L, Wang J, Jia H, Zhang B, Liu A, Du G. Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches. RSC Adv 2018;8:5286-97. [DOI: 10.1039/c7ra12259d] [Cited by in Crossref: 12] [Article Influence: 4.0] [Reference Citation Analysis]
363 Huang G, Yin L, Lan J, Tong R, Li M, Na F, Mo X, Chen C, Xue J, Lu Y. Synergy between peroxisome proliferator-activated receptor γ agonist and radiotherapy in cancer. Cancer Sci 2018;109:2243-55. [PMID: 29791764 DOI: 10.1111/cas.13650] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
364 Ferrara N. VEGF and Intraocular Neovascularization: From Discovery to Therapy. Transl Vis Sci Technol 2016;5:10. [PMID: 26981332 DOI: 10.1167/tvst.5.2.10] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
365 Lu J, Wang YH, Yoon C, Huang XY, Xu Y, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Zheng CH, Li P, Huang CM. Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis. Cancer Lett 2020;471:38-48. [PMID: 31811909 DOI: 10.1016/j.canlet.2019.11.038] [Cited by in Crossref: 50] [Cited by in F6Publishing: 60] [Article Influence: 25.0] [Reference Citation Analysis]
366 Shan X, Yu W, Ni X, Xu T, Lei C, Liu Z, Hu X, Zhang Y, Cai B, Wang B. Effect of Chitosan Magnetic Nanoparticles Loaded with Ang2-siRNA Plasmids on the Growth of Melanoma Xenografts in Nude Mice. Cancer Manag Res 2020;12:7475-85. [PMID: 32904466 DOI: 10.2147/CMAR.S250479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
367 Burgermeister E, Battaglin F, Eladly F, Wu W, Herweck F, Schulte N, Betge J, Härtel N, Kather JN, Weis CA, Gaiser T, Marx A, Weiss C, Hofheinz R, Miller IS, Loupakis F, Lenz HJ, Byrne AT, Ebert MP. Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A. EBioMedicine 2019;45:139-54. [PMID: 31300350 DOI: 10.1016/j.ebiom.2019.07.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
368 Zhu H, Ivanovic M, Nguyen A, Nguyen PK, Wu SM. Immune checkpoint inhibitor cardiotoxicity: Breaking barriers in the cardiovascular immune landscape. J Mol Cell Cardiol 2021;160:121-7. [PMID: 34303670 DOI: 10.1016/j.yjmcc.2021.07.006] [Reference Citation Analysis]
369 Laina A, Gatsiou A, Georgiopoulos G, Stamatelopoulos K, Stellos K. RNA Therapeutics in Cardiovascular Precision Medicine. Front Physiol. 2018;9:953. [PMID: 30090066 DOI: 10.3389/fphys.2018.00953] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
370 Liu M, Liu H, Zhou J, Yu Z. miR‑140‑5p inhibits the proliferation of multiple myeloma cells by targeting VEGFA. Mol Med Rep 2021;23:53. [PMID: 33200797 DOI: 10.3892/mmr.2020.11691] [Reference Citation Analysis]
371 Fueyo J, Hossain MB, Nguyen T, Gomez-Manzano C. Normalizing Tumoral Vessels to Treat Cancer: An Out-of-the-Box Strategy Involving TIE2 Pathway. Transl Cancer Res 2017;6:S317-20. [PMID: 28944168 DOI: 10.21037/tcr.2017.03.64] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
372 Yang J, Liu R, Ektare V, Stephens J, Shelbaya A. Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives. Appl Health Econ Health Policy 2021;19:605-18. [PMID: 33506318 DOI: 10.1007/s40258-021-00637-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
373 Katoh M, Katoh M. Molecular genetics and targeted therapy of WNT-related human diseases (Review). Int J Mol Med. 2017;40:587-606. [PMID: 28731148 DOI: 10.3892/ijmm.2017.3071] [Cited by in Crossref: 37] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
374 Roskoski R Jr. Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas. Pharmacol Res 2017;120:116-32. [PMID: 28330784 DOI: 10.1016/j.phrs.2017.03.010] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 27.5] [Reference Citation Analysis]
375 Bamias A, Gibbs E, Khoon Lee C, Davies L, Dimopoulos M, Zagouri F, Veillard AS, Kosse J, Santaballa A, Mirza MR, Tabaro G, Vergote I, Bloemendal H, Lykka M, Floquet A, Gebski V, Pujade-Lauraine E. Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial. Ann Oncol 2017;28:1842-8. [PMID: 28481967 DOI: 10.1093/annonc/mdx228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
376 Keklikoglou I, Kadioglu E, Bissinger S, Langlois B, Bellotti A, Orend G, Ries CH, De Palma M. Periostin Limits Tumor Response to VEGFA Inhibition. Cell Reports 2018;22:2530-40. [DOI: 10.1016/j.celrep.2018.02.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
377 Zarrilli G, Galuppini F, Angerilli V, Munari G, Sabbadin M, Lazzarin V, Nicolè L, Biancotti R, Fassan M. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. Int J Mol Sci 2021;22:3640. [PMID: 33807389 DOI: 10.3390/ijms22073640] [Reference Citation Analysis]
378 García-Caballero M, Quesada AR, Medina MA, Marí-Beffa M. Fishing anti(lymph)angiogenic drugs with zebrafish. Drug Discov Today 2018;23:366-74. [PMID: 29081356 DOI: 10.1016/j.drudis.2017.10.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
379 Ntellas P, Mavroeidis L, Gkoura S, Gazouli I, Amylidi AL, Papadaki A, Zarkavelis G, Mauri D, Karpathiou G, Kolettas E, Batistatou A, Pentheroudakis G. Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in Cancer. Cancers (Basel) 2020;12:E3145. [PMID: 33121034 DOI: 10.3390/cancers12113145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
380 Zhang L, Liu S, Wang J, Zou J, Zeng H, Zhao H, Zhang B, He Y, Shi J, Yoshida S, Zhou Y. Differential Expressions of microRNAs and Transfer RNA-derived Small RNAs: Potential Targets of Choroidal Neovascularization. Current Eye Research 2019;44:1226-35. [DOI: 10.1080/02713683.2019.1625407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
381 Tawara K, Scott H, Emathinger J, Ide A, Fox R, Greiner D, LaJoie D, Hedeen D, Nandakumar M, Oler AJ, Holzer R, Jorcyk C. Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion. Transl Oncol 2019;12:245-55. [PMID: 30439625 DOI: 10.1016/j.tranon.2018.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
382 Claesson-Welsh L. Alk1 (Activin Receptor-Like Kinase 1) and Vascular Hyperpermeability in Diabetic Retinopathy. Arterioscler Thromb Vasc Biol 2018;38:1673-5. [PMID: 30354200 DOI: 10.1161/ATVBAHA.118.311365] [Reference Citation Analysis]
383 Yao J, Yang Z, Huang L, Yang C, Wang J, Cao Y, Hao L, Zhang L, Zhang J, Li P, Wang Z, Sun Y, Ran H. Low-Intensity Focused Ultrasound-Responsive Ferrite-Encapsulated Nanoparticles for Atherosclerotic Plaque Neovascularization Theranostics. Adv Sci (Weinh) 2021;:e2100850. [PMID: 34382370 DOI: 10.1002/advs.202100850] [Reference Citation Analysis]
384 Carter PJ, Lazar GA. Next generation antibody drugs: pursuit of the 'high-hanging fruit'. Nat Rev Drug Discov 2018;17:197-223. [DOI: 10.1038/nrd.2017.227] [Cited by in Crossref: 322] [Cited by in F6Publishing: 296] [Article Influence: 80.5] [Reference Citation Analysis]
385 Wang R, Liu H, You YY, Wang XY, Lv BB, Cao LQ, Xue JY, Xu YG, Shi L. Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragments. Bioorg Med Chem Lett 2021;36:127788. [PMID: 33460739 DOI: 10.1016/j.bmcl.2021.127788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Etulain J. Platelets in wound healing and regenerative medicine. Platelets 2018;29:556-68. [DOI: 10.1080/09537104.2018.1430357] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 27.3] [Reference Citation Analysis]
387 Xue L, Maihle NJ, Yu X, Tang SC, Liu HY. Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth. Mol Pharm 2018;15:4801-13. [PMID: 30222359 DOI: 10.1021/acs.molpharmaceut.8b00388] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
388 Liu J, Wang J, Fu W, Wang X, Chen H, Wu X, Lao G, Wu Y, Hu M, Yang C, Yan L, Ren M. MiR-195-5p and miR-205-5p in extracellular vesicles isolated from diabetic foot ulcer wound fluid decrease angiogenesis by inhibiting VEGFA expression. Aging (Albany NY) 2021;13:19805-21. [PMID: 34370714 DOI: 10.18632/aging.203393] [Reference Citation Analysis]
389 Cooper SL, Carter JJ, March J, Woolard J. Long-term cardiovascular effects of vandetanib and pazopanib in normotensive rats. Pharmacol Res Perspect 2019;7:e00477. [PMID: 31164986 DOI: 10.1002/prp2.477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
390 Apte RS. Reducing Treatment Burden in AMD. Cell 2020;180:1033. [PMID: 32200797 DOI: 10.1016/j.cell.2020.02.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Cai W, Chen QY, Dang LH, Luesch H. Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors. ACS Med Chem Lett 2017;8:1007-12. [PMID: 29057042 DOI: 10.1021/acsmedchemlett.7b00192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
392 Lange C, Storkebaum E, de Almodóvar CR, Dewerchin M, Carmeliet P. Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol 2016;12:439-54. [PMID: 27364743 DOI: 10.1038/nrneurol.2016.88] [Cited by in Crossref: 128] [Cited by in F6Publishing: 124] [Article Influence: 25.6] [Reference Citation Analysis]
393 Lin R, Huang J, Wang L, Li Y, Lipowska M, Wu H, Yang J, Mao H. Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging. Biomater Sci 2018;6:1517-25. [PMID: 29652061 DOI: 10.1039/c8bm00225h] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]